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The main object of study of this dissertation is neurotransmitter release, a fun-
damental biological process implicated in memory and learning, emotions and
behavior, as well as many other crucial cellular functions. Transmitter release is
impaired in many diseases of the nervous system, including neurodegenerative
diseases.
Chapter 1 is an introduction to the mechanism of transmitter release by exo-
cytosis and related biological concepts studied in the current work. The physic-
ochemical techniques utilized to study exocytosis are introduced in Chapter 2.
The roles of filamentous actin and nonmuscle myosin II in chromaffin cell exocy-
tosis as examined by fluorescence microscopy, amperometry and cell-attached
capacitance methods are analyzed in Chapter 3. Improved microfabricated elec-
trochemical detector arrays, and their utilization in novel single cell measure-
ments are demonstrated in Chapter 4. Chapter 5 describes random walk sim-
ulations and time domain deconvolution methods for modeling transmitter re-
lease and diffusion. Monitoring dopamine levels in the brain of freely moving
research animals using a wired setup is presented in Chapter 6. Also in Chapter
6, the initial development of a wireless sensor for monitoring in vivo levels of
dopamine is demonstrated.
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CHAPTER 1
INTRODUCTION
1.1 Exocytosis
The communication between neurons is currently one of the more fascinating
subjects in cell biology (Fig. 1.1). A key process in neuronal communication is
exocytosis, during which membrane bound vesicles fuse with the cell plasma
membrane and secrete their compounds into the extracellular space [1] (Fig. 1.1
inset). Exocytosis forms a constitutive secretory pathway with which proteins and
lipids on the vesicle membrane reconstitute the cell plasma membrane, main-
taining the plasma membrane functionality. Exocytosis is also the means with
which cells produce and secrete many of the glycoproteins and proteoglycans
of the extracellular matrix. In addition to this constitutive pathway, which is
found in all cell types, exocytosis also forms a regulated secretory pathway, which
is found primarily in cells that are required to secrete compounds at high con-
centrations in response to specific stimulation. Depending on the cell type, the
released compounds can be hormones, neurotransmitters, peptides, enzymes or
other mediators.
Exocytosis of vesicles includes several steps, such as trafficking, which is the
translocation of vesicles from the Golgi apparatus to the cell membrane, tether-
ing, docking and priming, which associate vesicles closely with the cell plasma
membrane, fusion of the vesicle membrane with the cell plasma membrane, and
secretion of the intravesicular compounds into the extracellular space [2].
Key proteins in vesicle exocytosis are the SNARE (SNAP receptors, where
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Figure 1.1: A presynaptic and a postsynaptic neuron. Inset: zoomed-in view of
the synapse formed between the two neurons. Four synaptic vesicles filled with
neurotransmitter molecules can be seen inside the presynaptic neuron. One
of the vesicles is undergoing exocytosis, secreting neurotransmitters into the
synaptic cleft. Image from the National Institutes of Health (NIH).
SNAP stands for soluble NSF-attachment protein, and NSF stands for N-
ethylmaleimide-sensitive fusion protein) proteins [3]. In synaptic vesicle ex-
ocytosis the SNARE proteins include the vesicular protein VAMP (vesicle as-
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sociated membrane protein), also known as Synaptobrevin, and the plasma
membrane proteins Syntaxin and SNAP-25 (abbreviation for synaptosome-
associated protein of mass 25 kDa). According to the SNARE hypothesis [4],
the formation of a tight “SNARE complex” drives vesicle fusion [5]. Immedi-
ately following vesicle fusion with the cell plasma membrane, a nanometer size
connection is formed between the intravesicular and the extracellular spaces,
called the fusion pore [6]. Various compounds located within the vesicle are
secreted into the extracellular space through the fusion pore.
Figure 1.2: (Left) A vesicle depicted near the cell plasma membrane. The
schematic shows the three SNARE proteins: VAMP or Synaptobrevin, Syntaxin
and SNAP-25. (Middle) The formation of the “SNARE” complex associates the
vesicle and cell plasma membranes very closely. (Rigth) The schematic shows a
formed fusion pore through which molecules are secreted into the extracellular
space. Figure modified from [5].
1.2 Actin and myosin II
In addition to the SNARE proteins, which play a fundamental role in vesicle
exocytosis, there is a multitude of intracellular proteins which also contribute to
the process of single vesicle exocytosis. One aim of the present work is to illu-
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minate the role of two proteins, actin and myosin II, in the process of exocytosis.
Actin is a globular protein found in almost all eukaryotic cells. Inside the
cell, actin monomers dynamically polymerize to form filamentous actin in an
adenosine triphosphate (ATP) dependent manner (Fig. 1.3). Actin filaments are
essential for vesicle motility, particularly when the vesicles are in close proxim-
ity to the cell plasma membrane.
Figure 1.3: A schematic depicting an actin monomer (dark blue at the right)
about to be associated with filamentous actin. Image from the Protein Data
Bank.
nonmuscle myosin II is a molecular motor protein implicated in actin based
vesicle motility. Fig. 1.4 shows a myosin molecule. Nonmuscle myosin II con-
tains two heavy chains, which comprise the molecule’s two heads. The two
heavy chains converge to the neck region and continue to form the tail. Two
light chains (one known as “regulatory” and the other as “essential”) bind each
heavy chain at the neck region, such that each nonmuscle myosin II molecule
contains four light chains [7].
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Figure 1.4: The two heads of a myosin molecule converge to the neck and form
the tail. Only a small part of the tail is shown in this figure. Image from the
Protein Data Bank.
1.3 Chromaffin and mast cells
Chromaffin cells (Fig. 1.5) are neuroendocrine cells, found in the medulla of
the adrenal gland. These cells contain large dense core vesicles (LDCVs), which
store and secrete the catecholamine hormones norepinephrine and epinephrine
among other compounds. Exocytosis in chromaffin cells depends on entry of
Ca2+ ions inside the cells. Chromaffin cells constitute a model system to study
exocytosis, since the fusion of LDCVs with the cell plasma membrane can be
detected via capacitance measurement techniques (see section 2.2). Moreover,
LDCVs contain large amounts of electroactive catecholamines, the secretion of
which can be electrochemically (see section 2.3) monitored.
Mast cells (Fig. 1.6) are part of the immune system and they are best known
for their role in allergies. Mast cells are also known for their protective role,
since they are involved in wound healing and defense against pathogens. In ad-
dition to being rich in histamine and heparin, mast cell granules also contain the
electroactive compound serotonin, which can be electrochemically monitored.
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Figure 1.5: A transmission electron micrograph of a chromaffin cell. Chromaf-
fin cells contain 20,000 to 30,000 vesicles. The large oval body is the cell nu-
cleus. This image was obtained by quick-freezing and fracturing a chromaffin
cell. The fractured surface was stained using platinum and carbon. Image from:
http://webpages.ull.es/users/isccb12/ChromaffinCell/Primer.html
Figure 1.6: Scanning electron micrograph of a rat peritoneal mast cell. A widely
open fusion pore can be seen on the cell surface. Figure from [6].
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1.4 Measuring transmitter release in vivo
A fascinating system to study transmitter release is the brain, where neurotrans-
mitter secretion modulates, amongst others, behavior, thought, memory, learn-
ing, sexual behavior, and drug addiction. In vivo measurements of the electroac-
tive compound dopamine (DA) are particularly interesting in the striatum. The
bodies of dopaminergic neurons located in the substantia nigra project their ax-
ons into the striatum (Fig. 1.7).
Figure 1.7: A schematic depicting the projection of dopaminergic neurons
from the ventral tegmental area (light blue) and the substantia nigra pars
compacta (dark blue) to the striatum (maroon). Image modified from:
www.thebrain.mcgill.ca
Individual neurons secrete the neurotransmitter DA into the striatum, where
DA regulates motor function. In Parkinson’s disease, impaired DA release re-
sults in the symptoms characterizing the patients of this disease, such as un-
controllable tremor and slowness of movement. Although DA is electroactive
and its concentration can be monitored electrochemically, the amount of DA se-
creted by a single neuron is very low and can not be detected. However, when
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stimulated, a large number of neurons may simultaneously secrete DA into the
striatum. In this case, the amount of striatal DA reaches relatively high con-
centrations, allowing the detection of in vivo DA levels using electrochemical
techniques. These in vivo measurements have only been achieved recently in
the brain of freely moving research animals [8], and have allowed researchers
to correlate DA function with behavior [9].
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CHAPTER 2
TECHNIQUES FOR MONITORING EXOCYTOSIS
During the late 1940s and early 1950s the pioneering work of Sir Bernard Katz
and his colleagues Paul Fatt and Jose del Castillo, led to the discovery that
the endplate region of skeletal muscles was the site of spontaneous electrical
activity, caused by the discharge of packets of acetylcholine from nerve ter-
minals [10]. Katz and his colleagues demonstrated that these ’miniature end-
plate potentials’ represented the basis of chemical synaptic transmission. The
recognition that transmitter release was quantal coincided with the discovery
of presynaptic vesicles by electron microscopists. Katz and his colleagues re-
lated these two findings and suggested the ’vesicle hypothesis’ as the underly-
ing physical mechanism for quantal release.
Since the proposal of the ’vesicle hypothesis’, vesicular fusion and release
has become the object of intense research by many scientists in various educa-
tional and governmental institutions. Several techniques have been employed
to investigate single exocytotic events, including epifluorescence and total inter-
nal reflection fluorescence microcopy [11, 12, 13, 14, 15], whole cell patch clamp
capacitance measurements [16, 17, 18, 19], cell-attached capacitance measure-
ments [20, 21, 22, 23], carbon fiber amperometry [24, 25, 26], and patch amper-
ometry [27, 28, 29]. For the purposes of the present dissertation the author uti-
lized several biophysical techniques, a brief introduction to the basic concepts
of which follows.
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2.1 Fluorescence microscopy
Single vesicle exocytosis can be monitored using fluorescence microscopy. Flu-
orescence is the physical process wherein molecular absorption of a photon
leads to the subsequent emission of a photon of longer wavelength (or lower
frequency). There are many fluorophores that stain biological cells yielding flu-
orescence images. For example, the Lysotracker probes from Invitrogen (Molec-
ular Probes, Invitrogen Co.) are membrane permeable dyes which penetrate
and stain cell vesicles. During vesicular release, the probe is secreted along
with transmitter molecules and the secretion process may be monitored using
fluorescence microscopy techniques.
With the advent of the green fluorescent protein (GFP) and its derivatives,
cells can be tagged with fluorophores in an extremely specific manner, making
fluorescence microscopy a fundamental biophysical tool. Tagging fluorescent
proteins in a specific manner has allowed the investigation of the role that vari-
ous proteins play during exocytosis [30].
Another interesting fluorophore is Fura-2, which is a ratiometric fluorescent
dye widely used to measure Ca2+ concentrations [31]. Fura-2 selectively binds to
Ca2+ ions with a dissociation constant of 100-200 nM. Fig. 2.1 shows the excita-
tion spectrum of Fura-2 measured at 510 nm emission wavelength, for different
free Ca2+ concentrations. Interestingly at 358 nm excitation wavelength (isos-
bestic point), the fluorescence does not depend on the free Ca2+ concentration.
The ratio of the measured fluorescence intensities at a given excitation wave-
length over that at the isosbestic point is proportional to the level of free Ca2+.
Fura-2 thus provides an excellent tool to monitor in real time the effect of phar-
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macological treatment of cells on the level of free intracellular Ca2+. To deliver
Fura-2 in the intracellular environment one typically uses a patch-pipette in the
whole cell configuration [32]. Alternatively one could use Fura-2AM, which is a
membrane permeable derivative of Fura-2 that gets trapped inside the cells and
binds to free intracellular Ca2+.
Figure 2.1: Excitation spectrum of the ratiometric dye Fura-2 used for measuring
Ca2+ concentrations. Image from: http://www.invitrogen.com
In the present work Fura-2AM was utilized to visualize the effect of phar-
macological treatments of chromaffin cells on the level of free intracellular Ca2+,
before and after ionophore stimulation. These experiments were done to con-
firm that the observed effects of pharmacological treatments were due to their
specific inhibitory function and not because of side effects on Ca2+ channels,
affecting Ca2+ concentration at rest or following stimulation.
11
2.2 Cell-attached capacitance measurements
The space occupied by a biological cell is defined by the cell membrane. Cell
membranes are composed of lipid bilayers and membrane proteins, which are
dielectric materials. The ions present in the intra- and extracellular spaces are
separated by the cell membrane, forming the equivalent of an electrical capac-
itor. The specific capacitance of biological membranes is ∼ 0.8 − 1 µF/cm2. The
membrane capacitance C is given by the equation:
C =
0A
d
(2.1)
where  is the dielectric constant of the biological membrane, 0 = 8.85x10−12
F/m the permittivity of vacuum, A the cell membrane area, and d the membrane
thickness. During exocytosis, a vesicle fuses with the cell plasma membrane.
This fusion leads to an increase in the area of the cell plasma membrane, and
thus an increase in the cell capacitance. Therefore individual fusion events can
be detected as discrete capacitance steps [33]. For this purpose, standard patch-
clamp techniques [32] are used to form a giga-seal in the cell-attached configu-
ration [32, 21, 34] (Fig. 2.2).
To measure the cell-patch complex admittance, a reference electrode (chlo-
rinated silver wire: Ag|AgCl) is immersed in the extracellular solution, while a
second Ag|AgCl wire is inserted in the patch pipette, and a sine wave is applied
to the wire [33, 35]. Using a dual lock-in amplifier the real and imaginary parts
of the complex admittance are obtained.
For the cell-attached configuration, it can be shown that the complex admit-
tance of the patch-cell is given by [19, 20]:
Y =
GP + RAG2P + ω
2C2PRA + iωCP
(1 + RAGP)2 + (ωCPRA)2
(2.2)
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Figure 2.2: A schematic of a fire-polished glass pipette with a Ag|AgCl wire in
it. A slight suction applied to the glass pipette seals the cell surface creating
a patched membrane. The patched membrane area has a capacitance CP and
condunctance GP. The equivalent circuit also contains the access resistance RA,
the total cell membrane capacitance CC and the cell membrane conductance GC.
where CP and GP are the capacitance and conductance of the patched area, RA
is the access resistance, ω the angular frequency of the applied sine wave, and i
the imaginary unit. Equation (2.2) is derived with the assumption that the total
cell membrane capacitance CC can be ignored, since CC >> CP.
When a vesicle fuses with the cell plasma membrane a transient fusion pore
forms (Fig. 2.3). It can be shown that in the cell-attached configuration and
under proper phase compensation, the vesicle capacitance CV and the fusion
pore conductance GV are given by [19, 20]:
CV =
[(
Re2 + Im2)
)
/Im
]
/ω (2.3)
GV =
(
Re2 + Im2
)
/Re (2.4)
where Re and Im are the real and imaginary parts of the complex admittance
respectively. Therefore, measuring the real and imaginary parts of the admit-
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tance provides information about the vesicle size (capacitance) and the fusion
pore size (conductance).
Figure 2.3: A schematic of the patched area depicting a single vesicle fusion
event. CP and GP are the patched area capacitance and condunctance. CV and
GV are the vesicle capacitance and the fusion pore conductance. RA is the access
resistance.
2.3 Electrochemistry
Upon fusion with the cell plasma membrane, chromaffin vesicles secrete their
compounds into the extracellular space. The secreted compounds include the
catecholamines norepinephrine and epinephrine, which are electroactive, and
as such can be detected via electrochemical techniques. Most electrochemical
techniques utilized in biological experiments require a working electrode, a ref-
erence electrode, and in some cases, a counter electrode. In the vast majority of
biological electrochemical experiments, the working electrode is a carbon fiber
electrode (CFE) [36]. When a CFE is immersed in physiological saline, electri-
cal current can not flow across the electrode-electrolyte interface. In the CFE,
current is carried by electrons, while in the solution current is carried by ions.
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When a voltage is applied to the working electrode, excess charge accumulates
at the electrode surface facing the solution. To achieve electroneutrality, this
charge is compensated by counter ions spanning a finite distance in the solu-
tion, known as the Debye layer. When electroactive molecules diffuse to the
electrode surface, electrons are transferred leading to a current flow [37]. The
reference electrode is typically a Ag|AgCl, however it is not uncommon to use
a saturated calomel electrode [38]. Probably the two electrochemical techniques
most widely utilized by biophysicists are amperometry and fast-scan cyclic voltam-
metry.
2.3.1 Amperometry
The goal of amperometry is to reveal the time course of arrival of catecholamine
molecules to the working electrode, typically a CFE. For this purpose, the CFE
is held at a relatively high potential, usually +700 mV , such that upon contact
with the CFE surface, the two hydroxyl groups of the catecholamine benzene
ring (Fig. 2.4) are immediately oxidized. This oxidation leads to the donation
of two electrons per catecholamine molecule to the detection apparatus and the
conversion of the catecholamines to their ortho-quinone form (Fig. 2.5).
In a typical amperometric recording from a chromaffin cell, the CFE is in
close proximity to the cell surface, in some cases even in contact (Fig. 2.6). Since
chromaffin cell exocytosis depends on Ca2+ influx into the cell, a glass pipette
containing a high concentration of K+ ions is approached near the cell and a
slight pressure is applied to the pipette. This changes the balance of K+ ions
between the intra- and extracellular spaces, leading to a net inward K+ current,
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Figure 2.4: The biosynthetic pathway of catecholamines. Chromaf-
fin cells convert dopamine to norepinephrine in a reaction catalyzed by
dopamine-β-hydroxylase. Some chromaffin granules also contain the enzyme
phenylethanolamine-N-Methyltransferase, which catalyzes the conversion of
norepinephrine into epinephrine.
which in turn depolarizes the cell membrane and activates Ca2+ channels. Ca2+
entry into the cell stimulates exocytosis, and amperometric spikes are detected
(Fig. 2.7).
The oxidation current depends on the time course of secretion of cate-
cholamines from individual vesicles, as well as the time course of catecholamine
diffusion towards the CFE surface. Upon close examination (Fig. 2.8), individ-
ual current spikes have significantly different time courses, indicating that both
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Figure 2.5: A CFE (gray: wax insulation, white: active electrode) in amperomet-
ric mode (electrode potential is held constant at +700 mV . Upon contact with
the CFE surface, norepinephrine or epinephrine molecules are immediately ox-
idized to their ortho-quinone form. This oxidation generates two protons and
two electrons (enclosed in the gray circle at the top right). The two electrons
contribute to the amperometric current.
Figure 2.6: A CFE in contact with a bovine chromaffin cell. A glass pipette
containing 100 mM KCl solution is approached to the right of the cell. When
pressure is applied to the glass pipette, K+ ions stimulate the cell and exocytotic
activity is monitored via the CFE.
vesicular secretion and catecholamine diffusion may vary between individual
exocytotic events.
A small ’foot’ occurs at the initial phase of many amperometric spikes [25]
(Fig. 2.9). This amperometric current, known as the “foot-signal” [25] indi-
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Figure 2.7: Amperometric spikes detected by a CFE in contact with a chromaffin
cell.
Figure 2.8: Three amperometric spikes shown on an expanded time scale. The
spikes were measured by a CFE in contact with the surface of a bovine chromaf-
fin cell.
cates the catecholamine flux during the initial fusion pore formed when a vesi-
cle fuses with the cell plasma membrane [27].
Integration of the amperometric current spike (Fig. 2.9) reveals the measured
charge, which is directly proportional to the amount of oxidized catecholamine
molecules:
Q(t) =
∫
Idt = zeN (2.5)
where z is the number of electrons transferred per reacted molecule (two for
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catecholamines), e = 1.6x10−19 C the elementary charge, and N the number of
oxidized catecholamine molecules.
Figure 2.9: A single amperometric spike (A) and its integrated trace (B). The
integrated trace reveals the charge measured by the electrode, and is directly
proportional to the number of oxidized catecholamine molecules. The two rect-
angles indicate the foot signal current and charge.
2.3.2 Fast-scan cyclic voltammetry
Amperometry detects any electroactive compound but provides no information
about the nature of the compounds. The goal of fast-scan cyclic voltammetry
(FSCV) is to monitor the concentration of a specific analyte with subsecond tem-
poral resolution. For this purpose, a periodic triangular waveform is applied to
the CFE (Fig. 2.10).
During the anodic ramp (positive slope) of the triangular waveform, cate-
cholamines in contact with the CFE surface are oxidized to their ortho-quinone
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Figure 2.10: A CFE (gray: wax insulation, white: active electrode) in FSCV
mode: a periodic triangular voltage waveform is repetitively applied to the elec-
trode. During the anodic ramp of the triangular waveform, norepinephrine or
epinephrine molecules are oxidized to their ortho-quinone form, while during
the subsequent cathodic ramp the ortho-quinones are reduced back to the orig-
inal catecholamines. The gray circle shows the two electrons that are detected
during the anodic ramp. Two electrons are donated back during the cathodic
ramp. The gray dot on the anodic ramp shows the potential at which the cur-
rent is sampled to monitor voltammetric spikes (see text).
form, in a fashion similar to amperometry. However, during the subsequent ca-
thodic ramp (negative slope), the ortho-quinones are reduced back to the origi-
nal catecholamines (Fig. 2.10). Therefore the catecholamines are not consumed
as in amperometry and the time course of voltammetrically measured spikes re-
veals the time course of diffusion of catecholamines away from the CFE surface.
As mentioned above, when an electrode is immersed in an electrolyte, a dif-
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fuse double layer is created to compensate the electrode potential. This forms
a capacitor, which is charged and discharged [38] during the applied voltage
ramps, resulting in a large capacitive current, known as the background current
(Fig. 2.11, dashed black trace). Therefore the redox current, also known as the
faradaic current, is superimposed onto the background current (Fig. 2.11, solid
red trace). To reveal the identity of the detected molecule, the background cur-
rent must be subtracted from the total current, such that only the faradaic cur-
rent remains (Fig. 2.11, blue trace). Plotting the faradaic current versus the ap-
plied potential produces the background-subtracted voltammogram (Fig. 2.12).
The advantage of FSCV is that molecules can be distinguished based on the
different background-subtracted voltammograms.
Figure 2.11: Background (dashed black trace) and background plus faradaic
(solid red trace) currents plotted versus time. The difference between the two
reveals the faradaic current (blue trace).
FSCV in single chromaffin cells revealed that some vesicles secrete
norepinephrine, some others epinephrine, yet a few both of these cate-
cholamines [39]. Fig. 2.13A shows a voltammetric recording from a single chro-
maffin cell, where multiple FSCV spikes are detected. Fig. 2.13B shows the
background-subtracted voltammogram for the spike indicated by the arrow in
Fig. 2.13A. The voltammogram reveals the chemical identity of catecholamine
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Figure 2.12: The faradaic current is plotted versus the applied potential and re-
veals the background-subtracted voltammogram for catecholamine molecules.
During the anodic ramp catecholamines are oxidized to their quinone form
(solid trace), while during the cathodic ramp the quinones are reduced back
to the original catecholamine (dotted trace).
Figure 2.13: (A) Voltammetric spikes recorded from a bovine chromaffin cell
using a CFE. The current was sampled at the +400 mV potential of the anodic
ramp. The horizontal bar indicates the duration of the K+ application. (B) The
background-subtracted voltammogram for the spike indicated by the arrow in
(A) reveals the identity of catecholamine molecules.
molecules. Fig. 2.14 shows, on an expanded time scale, a single FSCV spike with
a foot signal of ∼100 ms duration. The background-subtracted voltammograms
during the foot and the spike peak are of different amplitude but similar shape,
because they indicate the same secreted compound at different concentrations
(inset of Fig. 2.14).
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Figure 2.14: A single voltammetric spike is shown on an expanded time scale.
The voltammetric current is sampled at the +400 mV potential of the anodic
ramp. The background subtracted voltammograms (shown in the inset) for the
peak and the foot are identical and correspond to catecholamine molecules.
2.4 Microfabrication techniques
Since the famous 1959 speech of Richard Feynman ”There’s Plenty of Room
at the Bottom” [40] microtechnology has forever changed many scientific fields.
Very recently, and with a delay of several decades from the invention of the tran-
sistor, innovative researchers started adopting microfabrication technologies for
biological research.
Micro- and nanofabricated devices emerge as powerful tools to study cellu-
lar function on the nanoscale. An excellent example of utilizing microtechnolo-
gies to study cell function are the electrochemical detector (ECD) arrays [41].
ECD arrays of platinum microelectrodes have been fabricated to monitor chro-
maffin cell exocytosis with simultaneous amperometric recording and fluores-
23
cence imaging [42]. Amperometric recording with platinum electrodes are of
similar quality as CFE recordings and the measured signals are consistent be-
tween the two types of electrodes [42]. This approach allowed correlation of
amperometrically detected release with fluorescence signals with precision of
a few hundred nanometers. In the present work we demonstrate advances in
the ECD array fabrication process, which allow for improved spatiotemporal
characterization of exocytosis and stimulus-secretion coupling.
2.5 Random walk simlations
Diffusion is the random motion of molecules in a medium. Passive transport
of molecules from a region of higher to another of lower concentration occurs
by diffusion. When no external forces are present, and the temperature in the
system is uniform, diffusion will eventually equilibrate the concentration. In-
terestingly, diffusion is the mechanism with which neurotransmitters secreted
from a presynaptic terminal transverse the synaptic cleft to reach receptors at
the postsynaptic neuron. Diffusion is also the means with which catecholamines
secreted from a vesicle reach the CFE surface. Thus the amperometric or voltam-
metric spike time course also contains information about the diffusion of cate-
cholamines towards the CFE surface. The diffusive flux J is related to the con-
centration C of the diffusing species according to Fick’s first law:
J = −D 5 c = −D
(
∂
∂x
+
∂
∂y
+
∂
∂z
)
c (2.6)
where D is the diffusion constant. Fick’s second law relates the diffusion to the
resulting change in concentration:
∂
∂t
c = D 52 c = D
(
∂2
∂x2
+
∂2
∂y2
+
∂2
∂z2
)
c (2.7)
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For the case of a single CFE placed directly in front of a chromaffin cell, and
assuming instantaneous catecholamine release from the vesicles, the measured
amperometric current can be approximated by an analytical solution of the one
dimensional diffusion equation [25]:
I =
n+1∑
i=−n
(−1)iN(z − 2iz)
2t
√
piDt
exp
(−(z − 2iz)2
4Dt
)
(2.8)
where z is the cell-detector distance, N the number of detected molecules, D the
diffusion constant, t the time, and the summation is extended from -7 to +8.
However, if complicated cell-electrode geometries are to be utilized, as in the
case of ECD arrays (see above, section 2.4), Fick’s second law can not be inte-
grated to provide an analytical expression for the measured oxidation currents.
Note that one can not numerically integrate Green’s function over the ECD ar-
rays, because this will not take into account the molecules reflected at the glass
coverslip between the active electrodes. A different approach in this case is to
model catecholamine diffusion as a random walk [43], such that the trajectory
of each molecule consists of consecutive random jumps. Although computa-
tionally slow for large number of molecules, this method provides a solution to
modeling diffusion in an arbitrary geometry.
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CHAPTER 3
F-ACTIN AND MYOSIN II ACCELERATE CATECHOLAMINE RELEASE
FROM CHROMAFFIN GRANULES
3.1 Abstract
The roles of nonmuscle myosin II and cortical actin filaments in chromaffin
granule exocytosis were studied by confocal fluorescence microscopy, amper-
ometry, and cell-attached capacitance measurements. Fluorescence imaging in-
dicated decreased mobility of granules near the plasma membrane following
inhibition of myosin II function with Blebbistatin. Slower fusion pore expan-
sion rates and longer fusion pore lifetimes were observed after inhibition of
actin polymerization using cytochalasin D. Amperometric recordings revealed
increased amperometric spike half-widths without change in quantal size after
either myosin II inhibition or actin disruption. These results suggest that actin
and myosin II facilitate release from individual chromaffin granules by accel-
erating dissociation of catecholamines from the intragranular matrix possibly
through generation of mechanical forces.
3.2 Introduction
Chromaffin cells of the adrenal gland are a widely used model system to
study exocytosis [2]. The kinetics of catecholamine release from single chro-
maffin granules has been characterized in great detail using various ap-
proaches, such as amperometry [24], capacitance measurements [21] and patch-
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amperometry [27]. The small foot signal preceding amperometric spikes [25] is
an indication of catecholamine release through the fusion pore formed between
the vesicular lumen and the extracellular space, upon fusion of the secretory
vesicle with the cell plasma membrane [27].
Experimental evidence has been accumulated suggesting a role for the actin
cytoskeleton in regulating neuroendocrine cell exocytosis [44]. According to the
current view, a meshwork of filamentous actin (F-actin) underneath the plasma
membrane acts as a physical barrier to exocytosis [45] that must be disassembled
for vesicles from a reserve pool to enter the release-ready pool [46]. However,
this model has been challenged by recent findings that suggest the participation
of molecular motors, such as myosin Va, nonmuscle myosin II and other actin
binding proteins [44] in dynamic interactions with actin, supporting a more spe-
cific role for actin in the process of exocytosis.
Biochemical studies have demonstrated association of myosin Va with chro-
maffin granules and reduction in secretion with anti-myosin V antibodies in
permeabilized chromaffin cells has been reported [47]. More recently, it was
shown that pharmacological inhibition of myosin II and overexpression of an
unphosphorylatable mutant of the regulatory light chain (RLC) of myosin II
slowed down chromaffin granule movement as well as catecholamine release
from single chromaffin vesicles [48, 49].
However, the interaction between the actin cytoskeleton and the myosin
molecular motors and how their interplay regulates secretion is unclear, specif-
ically because myosin V but not myosin II has been found to interact with chro-
maffin granules [47]. If the modulation of release kinetics by myosin II is me-
diated by interactions with actin filaments, then inhibiting actin polymeriza-
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tion would be expected to also affect individual secretory events. To investi-
gate the roles of actin and myosin II in chromaffin granule exocytosis, in par-
ticular fusion pore properties, and catecholamine release from single vesicles,
we performed fluorescence microscopy, amperometry and cell-attached capac-
itance recordings on single chromaffin cells following inhibition of either actin
polymerization or the ATPase activity of myosin II.
3.3 Materials and Methods
3.3.1 Cell preparation, reagents and solutions
Bovine chromaffin cells were prepared as previously described [50]. The
buffered solution used for all the amperometric, capacitance and fluorescence
measurements contained (in mM) 140 NaCl, 5 KCl, 5 CaCl2, 1 MgCl2, 10
HEPES/NaOH, 20 glucose (pH 7.3). The pipette solution used for the capac-
itance recordings contained (in mM) 50 NaCl, 100 TEA-Cl, 5 KCl, 5 CaCl2, 1
MgCl2, 10 HEPES/NaOH (pH 7.3). Ionomycin was purchased from Sigma and
stock solution was prepared in ethanol. (-)-blebbistatin, cytochalasin D, 1-(5-
Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride (ML-
7), and latrunculin A were all purchased from Sigma and stock solutions were
prepared in dimethylsulfoxide. Immediately prior to the beginning of an ex-
perimental session, stock solutions were diluted in the bath solution at a final
concentration of 10 µM for Ionomycin, 4 µM for cytochalasin D, 10 µM for bleb-
bistatin, 3 µM for ML-7, and 2 µM for latrunculin A. Chromaffin cells were incu-
bated with the different inhibitors for 15 min at 37oC and 10% CO2 immediately
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prior to the recordings. A similar incubation was performed for control cells
in order to take into account possible temperature effects on exocytotic activ-
ity [51].
3.3.2 Fura-2 calcium imaging
Coverslips containing the chromaffin cells were placed in a Petri dish contain-
ing 3 µM cell permeant Fura-2AM (Molecular Probes, Invitrogen Co.) for 15 min.
The cells were then gently washed twice with buffer solution such that the dye
was removed and either buffer solution (control), 10 µM blebbistatin, or 4 µM
cytochalasin D was added onto the cells. The dishes were mounted on a custom
built stage for an inverted microscope (Zeiss Axiovert 135 TV) equipped with
a Zeiss FT425 dichroic filter and a Schott GG495 emission filter, and protected
from light for a period of 10 min prior to imaging. The fluorescence intensity
was recorded using 100 ms exposures at a rate of 0.2 Hz for a total period of
150 s using a charge-coupled device (iXon EMCCD, Andor Technology). At
each time point a pair of images was acquired, using a filter wheel (Lambda
10-2, Sutter Instruments) to switch between 358 nm and 390 nm excitation wave-
lengths. Images were stored as 16-bit integer matrices and were analyzed using
custom written procedures in Igor Pro. The background fluorescence intensity
was determined for each image at each wavelength in the sequence of images
by taking the average plus three standard deviations of the intensity measured
from a ∼20 µm2 square region in each image in an area which did not contain
any cells or floating particles. For each image the background was subtracted
from the average fluorescence intensity from a ∼20 µm2 square region within
each cell. The ratio of the Ca2+ sensitive (390 nm) over the Ca2+ insensitive (358
29
nm) channel was then obtained. The response from all the cells within a treat-
ment group was averaged at each time point. The data is presented as MEAN
± SEM, where n=12 cells for control, 24 cells for blebbistatin, and 15 cells for
cytochalasin D-treated cells. Student’s unpaired T-test was used to obtain the
statistical significance of the measured data.
3.3.3 Quantification of cortical actin
Chromaffin cells treated with the different inhibitors were fixed with 3.7%
formaldehyde for 10 min after 30 min incubation with the inhibitor at 37oC. Cells
were then permeabilized with 0.1% Triton X-100 for 5 min and actin filaments
labeled with Alexa 568 phalloidin. Confocal microscopy was performed with
a Leica TCS SP2 system with an acoustic optic-tunable filter and a 63x 0.9 NA
water immersion objective. The density of cortical actin was quantified at the
equatorial plane by integrating the total fluorescence intensity in an annular re-
gion containing the cell plasma membrane and dividing by the annulus area.
The annular width was kept constant to 1.5 µm.
3.3.4 Vesicle tracking
Chromaffin granules were labeled with 3 µM LysoTracker Green (Molecular
Probes, Invitrogen Co.) for 5 min before imaging. Confocal microscopy was
performed using the system described above with an optical slice thickness of
∼ 0.9 µm at the interface between the glass surface and the cell plasma mem-
brane. Images were acquired at a frame rate of 1.67 s−1 and the coordinates of
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individual vesicles were obtained by using the public domain program ImageJ.
The vesicle tracking plug-in used was an implementation of an algorithm pre-
viously described [52]. Vesicles were automatically detected by the program
after setting criteria for vesicle image size (circular spot of ≤ 500 nm diame-
ter) and cut-off intensity (50% of the brightest particles detected). Vesicles were
followed for several frames as long as they remained detected as a particle by
the program. All tracks were overlaid with the original time series and visu-
ally inspected for accuracy. Only tracks longer than 10 frames were used for
the analysis. After setting the selection criteria for vesicle size, cut-off intensity
and trajectory length, 9-17 vesicles per cell were left for analysis from which the
9-10 brightest were chosen per cell to ensure that the tracking occurred for a
similar number of vesicles per cell for all treatment groups. Mean squared dis-
placements (MSD) were calculated as described [53] using a custom MATLAB
(MathWorks) routine using the equation:
MSD(nδt) =
1
N − n
N−n∑
j=1
(
(x( jδt + nδt) − x( jδt))2 + (y( jδt + nδt) − y( jδt))2
)
(3.1)
where n and j are positive integers with n = 1, 2, ...(N − 1). (x( jδt), y( jδt)) and
(x( jδt + nδt), y( jδt + nδt)) are the granule’s coordinates at time jδt and jδt + nδt
respectively [54]. Data was fitted to a simple diffusion model: MSD(nδt) =
4Dnδt+c, where D is the diffusion coefficient and c is a constant that accounts for
the limited accuracy of the experimental setup [54]. All experiments were car-
ried out in 35 mm Petri dishes with coverglass bottoms (0.16 – 0.19 mm, MatTek,
Ashland, MA).
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3.3.5 Amperometry
Amperometry was performed using custom made CFEs and a patch-clamp am-
plifier (EPC-8, HEKA-Elektronik, Germany). The current was low pass filtered
at 500 Hz using the built-in analog low pass filter of the EPC-8 amplifier. The
CFE was in touch with the cell surface, as verified visually by a slight defor-
mation of the cell membrane. The CFE voltage was held at +700 mV versus a
Ag|AgCl reference electrode. A glass pipette with ∼2.5 µm tip diameter contain-
ing 10 µM ionomycin solution was positioned ∼40 µm away from the cell and a
3 s 3.5 x 104 Pa puff was applied to the pipette using a pressure application sys-
tem (PicoSpritzer II, Parker-Hannifin/General Valve, Fairfield, NJ) to stimulate
exocytosis. Amperometric recordings were performed for 10 min after stimu-
lation and the data was digitized at 2 kHz rate by a 16-bit resolution NIDAQ
board (BNC-2090, National Instruments, Austin, TX). A digital notch filter at
60 Hz (Igor Pro, WaveMetrics, Lake Oswego, OR) was used to remove line fre-
quency noise. Recordings were analyzed as previously described (Mosharov
and Sulzer, 2005). Spikes with amplitude less than 10 pA, or half-width more
than 300 ms, and overlapping spikes were excluded from the analysis. The 10
pA threshold was high enough for amperometric signals to be discerned from
noise and low enough for the majority of amperometric spikes in all treatment
groups to be included in the data analysis. The thresholds used for identifying
foot signals were 1 pA amplitude and 5 ms duration.
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3.3.6 Cell-attached capacitance measurements
High resolution capacitance measurements were performed in the cell-attached
configuration as previously described [21] using a HEKA EPC-7 amplifier and
patch pipettes of nominal resistance between 1 and 2 MΩ. A dual lock-in ampli-
fier (SR 830, Stanford Research Instruments, Sunnyvale, CA) was used to obtain
the complex admittance using a 50 mV-rms amplitude and 20 kHz frequency
sine wave applied to the patch pipette. The lock-in amplifier outputs were digi-
tized at 1 kHz rate by two 16-bit resolution channels of the NIDAQ board. Cus-
tom written software [34] in Igor Pro converted the two orthogonal traces (real
and imaginary parts) into measurements of vesicle capacitance CV (units of f F)
and fusion pore conductance GV (units of nS ) as described [21]. From these
recordings, vesicle size CV , fusion pore lifetime, fusion pore conductance, and
fusion pore expansion rate were derived as described [34]. For this analysis,
only exocytotic events with lifetime ≥15 ms were used [34], since shorter events
were heavily affected by the lock-in low-pass filters (τ=1 ms, 24 dB, which cor-
responds to 10 - 90% risetime of 5 ms) and their conductance properties are not
reliably determined. The fusion pore initial expansion rate was calculated as
the slope of a linear fit to the initial 15 ms segment of the conductance trace. The
fusion pore lifetime was the time from fusion pore opening until the fusion pore
conductance value exceeded 2 nS [34].
3.3.7 Statistical analysis
All reported signal parameters, amperometric (quantal size, half-width,
spike amplitude, mean foot signal amplitude and foot duration) and patch-
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capacitance (vesicle size, fusion pore initial and average conductance, fusion
pore initial expansion rate and fusion pore lifetime), were statistically analyzed
by taking the median values of the events from individual cells and subse-
quently averaging these values per treatment group. Therefore, data is repre-
sented as MEAN ± SEM, where n is the number of cells in each treatment group.
Differences were considered to be statistically significant for p < 0.05 as assessed
by Student’s unpaired T-test for both the amperometric and patch-capacitance
data. All experiments were performed at room temperature at day 1 after cell
isolation. The data came from two and four different cell preparations for am-
perometry and capacitance respectively.
3.4 Results
To investigate the roles of actin and nonmuscle myosin II in exocytosis of chro-
maffin granules we used cytochalasin D and latrunculin A, which inhibit actin
polymerization, blebbistatin, a specific inhibitor of nonmuscle myosin II [55],
and ML-7, an inhibitor of myosin light chain kinase (MLCK).
3.4.1 Calcium levels are not affected by blebbistatin or cytocha-
lasin D treatment
In order to evaluate the specificity of these pharmacological manipulations it
was first confirmed that the drug treatments did not affect intracellular Ca2+
levels at rest or Ca2+ influx following stimulation by ionomycin. For this pur-
pose, chromaffin cells were labeled with the ratiometric dye Fura-2 and imaged
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using fluorescence microscopy. The ratio of the fluorescence intensity at 390 nm
over 358 nm excitation wavelength was measured before addition of ionomycin
and found to be similar between control and blebbistatin (p > 0.64) and between
control and cytochalasin D (p > 0.65) treated cells (Fig. 3.1A). This indicates that
the pharmacological manipulations used in our study had no effect on the levels
of intracellular Ca2+ at rest.
Another possible indirect effect of the pharmacological agents would be to
influence Ca2+ influx following stimulation by ionomycin. To test this, a glass
pipette with ∼5.0 µm tip diameter containing 10 µM ionomycin solution was
positioned ∼20 µm away from the cells and a 30 s 1.0 x 104 Pa puff was ap-
plied to the pipette using a pressure application system (PicoSpritzer II, Parker-
Hannifin/General Valve, Fairfield, NJ) to promote Ca2+ entry into the cells. The
Ca2+ dynamics were monitored as fluorescence intensity ratios obtained every
5 s for a total of 150 s (30 images). The response of all the cells per treatment
group was averaged at each time point to obtain the average time course of in-
tracellular Ca2+ levels for each treatment group. No significant difference was
observed between control, blebbistatin and cytochalasin D-treated cells (Fig.
3.1B). The minimum of the averaged ratios, which occurs when the intracel-
lular Ca2+ amount is maximum, was similar for all treatment groups (control
and blebbistatin: p = 0.46, control and cytochalasin D: p = 0.80). These results
thus clearly indicate that there is no difference between treatment groups in the
intracellular Ca2+ levels at rest (Fig. 3.1A) or in the amount of Ca2+ influx fol-
lowing ionomycin stimulation of chromaffin cells (Fig. 3.1B). Furthermore, the
results indicate that following ionomycin stimulation of chromaffin cells, intra-
cellular Ca2+ levels remain relatively high and do not return to the pre-stimulus
baseline (Fig. 3.1B).
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Figure 3.1: Effects of cytochalasin D and blebbistatin on chromaffin cell calcium
levels. Ratio of fluorescence intensity excited at 390 nm over 358 nm. Response
from cells at rest (A) and following addition of ionomycin (B). Data is mean ±
SEM, n=12 cells for control, 24 cells for blebbistatin and 15 cells for cytochalasin
D.
3.4.2 Blebbistatin treatment decreases vesicular motion
Myosin II and the actin cytoskeleton have been implicated in vesicular mo-
tion [48]. We characterized vesicular movement in unstimulated cells using
confocal microscopy focused on the actin rich cortical region of the cell (Fig.
3.2A).
For this purpose, we tracked the motion of 94 vesicles from 9 untreated cells
and 92 vesicles from 10 cells treated with blebbistatin. The x and y coordinates
of each vesicle were tracked in a series of images (Fig. 3.2B) and converted into
MSD for that particular vesicle. These were then averaged for all the cells per
treatment group and plotted versus time (Fig. 3.2C). A linear fit to the data
(Fig. 3.2C), revealed the apparent diffusion coefficient for the vesicles in each
treatment group. The resulting apparent diffusion coefficients were 2.07 ± 0.06
x10−3 µm2/s for control cells and 6.8 ± 0.8 x10−4 µm2/s for blebbistatin-treated
cells, thus ∼3 fold lower in cells where the ATPase activity of myosin II was
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Figure 3.2: (A) Confocal micrograph of a representative cell used for vesicle
tracking. Vesicles were labeled with Lysotracker green for 5 min and then im-
aged at 25oC without stimulation. Scale bar represents 20 µm. (B) Trace of typical
xy coordinates followed by a single vesicle taken from control cells. (C) Plots of
two dimensional MSD calculated for control and blebbistatin-treated cells. Data
is presented as mean ± SEM for 94 vesicles from 9 control cells, and 92 vesicles
from 10 blebbistatin-treated cells.
specifically inhibited compared to control cells.
3.4.3 Cytochalasin D but not blebbistatin affects cortical actin
distribution
To test if the decreased mobility following inhibition of myosin II is a con-
sequence of cortical actin destabilization, fluorescence microscopy was used
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to determine how cytochalasin D and blebbistatin treatment affected the dis-
tribution of cortical actin fluorescence. As expected, cytochalasin D-treated
cells, showed disruption of cortical actin in contrast to blebbistatin-treated cells,
which showed a similar distribution as control cells (Fig. 3.3A). Quantitative
analysis (Fig. 3.3B) showed a 44% decrease in cortical actin fluorescence inten-
sity (p < 0.001) in cytochalasin D-treated cells, while blebbistatin-treated cells
showed no significant difference (p > 0.35) when compared to control cells (Fig.
3.3C). These results indicate that the observed changes in vesicle mobility as
well as the observed changes in release event properties (see below) are a direct
consequence of myosin II inhibition in the absence of cortical actin disintegra-
tion.
3.4.4 Inhibition of myosin II slows individual release events
The kinetics of catecholamine release from single vesicles was determined by
carbon fiber amperometry. Fig. 3.4A shows a typical recording from a chromaf-
fin cell under control conditions. To characterize the average release kinetics
an average amperometric spike shape was constructed (Fig. 3.4B). All ampero-
metric signals detected from a single cell with amplitude >10 pA and half-width
<300 ms were normalized to their peak amplitude, aligned in time at the point of
their maximum slope (occurring shortly before the spike maximum) and aver-
aged, providing the average spike shape for this cell. Subsequently, the average
spikes from each cell in a treatment group were again averaged in the same way
to obtain the average spike shapes for the different groups. Last, the averaged
spikes for the three groups were normalized such that they all had the same
quantal size, consistent with the statistical analysis of integrated amperometric
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Figure 3.3: Effects of inhibition of actin polymerization and myosin II function
on cortical actin distribution. (A) Confocal micrographs of chromaffin cells in
control condition, and treated with 10 µM blebbistatin or 4 µM cytochalasin D.
Cells were fixed after 30 min incubation with the inhibitor and stained for F-
actin with Alexa 568 phalloidin. Scale bar represents 20 µm. (B) Schematic de-
picts the quantification of cortical actin. A circular region of interest inside the
cell was subtracted from another region covering the entire cell. The annular
width was kept equal to 1.5 µm for all cells. (C) Quantified fluorescence of Alexa
568-palloiding labeled F-actin on the cortical region. Fluorescence values were
normalized to the mean value for control cells. Data is presented as MEAN ±
SEM from a total of 20 cells per group, triple asterisks represent p < 0.001 from
Student’s unpaired t-Test.
charge (see below). Both, blebbistatin and cytochalasin D-treated cells showed
reduced spike amplitude with increased half-width.
To determine the statistical significance of the changes in amperometric
spike properties, five parameters were determined for each spike: quantal size,
amperometric spike half-width, peak amplitude, mean foot current amplitude
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Figure 3.4: (A) A typical recording from an untreated chromaffin cell stimulated
with ionomycin. (B) Spikes from each cell were normalized to their peak am-
plitude, aligned in time at the point of their maximum slope (occurring shortly
before the spike maximum) and averaged, providing the average spike shape
for this cell. The average spikes from each cell in a treatment group were again
averaged in the same way to obtain the average spike shapes for control (CT,
n = 19 cells, 786 spikes), blebbistatin-treated (BL, n = 18 cells, 633 spikes) and
cytochalasin D-treated (CD, n = 18 cells, 1229 spikes) cells. Last, the averaged
spikes were normalized to the same quantal size. The half-widths of these av-
eraged spikes were 11.9 ms for control, 18.7 ms for blebbistatin-treated, and 26.0
ms for cytochalasin D-treated cells.
and foot signal duration (Fig. 3.5A) [56]. When the average spike half-width
was determined for each cell and the mean for all cells in a treatment group was
calculated, values of 12.7 ± 1.0 ms (control), 18.6 ± 1.2 ms (blebbistatin), and 24.7
± 2.2 ms (cytochalasin D) were obtained, in excellent agreement with the values
from the averaged spikes (Fig. 3.4B).
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A more robust method avoiding spurious artifacts due to outliers is to deter-
mine the median value for each spike parameter for each cell and subsequently
calculate the mean of these median values for each treatment group (Fig. 3.5B-
G) [56]. The half-widths determined with this method after normalizing to the
control values were 100 ± 7.9 % (control, n = 19 cells), 153.5 ± 8.9 % (blebbis-
tatin, n = 18 cells), and 224.8 ± 22.8 % (cytochalasin D, n = 18 cells), confirming
that the observed increase in spike half-width due to inhibition of myosin II
function or due to inhibition of actin polymerization are highly significant (Fig.
3.5B). Consistent with these results, the inhibition of MLCK with the inhibitor
ML-7 also increased the amperometric half-widths to a similar value as blebbis-
tatin (145.3 ± 12.2 %, p < 0.01, Fig. 3.5B). The increases in amperometric spike
half-width by these treatments were accompanied by decreases in amperomet-
ric spike amplitude (Fig. 3.5C) with no significant changes in quantal size (Fig.
3.5D).
To test whether the effects of cytochalasin D were specifically due to inhibi-
tion of actin polymerization, amperometric recordings were also performed in
cells treated with latrunculin A, which also hinders actin polymerization. La-
trunculin A treatment produced an increase of amperometric spike half-width
and decrease of spike peak amplitude without affecting quantal size (Fig. 3.5B-
D), indistinguishable from the effects of cytochalasin D, indicating that these
changes are specific consequences of actin depolymerization.
The number of exocytotic events recorded within 10 min after stimulation
was unchanged when myosin II was inhibited (Fig. 3.5E). In contrast, in cells
treated with ML-7 the number of events was significantly reduced to 33% of
control (Fig. 3.5E, p < 0.01). This suggests that inhibition of MLCK by ML-7
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Figure 3.5: (A) A single amperometric spike along with the five parameters:
quantal size Q (pC), half-width (ms), peak amplitude (pA), foot signal dura-
tion (ms), and mean foot current (pA). Averaged values for half-width (B), peak
amplitude (C), quantal size (D), number of exocytotic events (E), mean foot cur-
rent (F), and foot signal duration (G) for control (CT, n = 19 cells, 786 spikes),
blebbistatin (BL, n = 18 cells, 633 spikes), cytochalasin D (CD, n = 18 cells, 1229
spikes), ML-7 (ML7, n = 20 cells, 388 spikes), and latrunculin A (LatA, n = 10
cells) expressed as percentage of control values (always taken to be 100%). Data
is represented as MEAN ± SEM, where n is the number of cells. Differences
between treatment groups were tested for statistical significance by Student’s
unpaired t-Test and are indicated by single (p < 0.05), double (p < 0.01) or triple
(p < 0.001) asterisks.
may affect other non myosin II molecules, consistent with recent evidence [57],
leading to the observed reduction in exocytotic events. However, in contrast
to blebbistatin and ML-7, cytochalasin D or latrunculin A treatment increased
the number of spikes by ∼66% compared to control cells (Fig. 3.5E), in good
agreement with the proposed role of actin as a barrier to exocytosis [45, 47].
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3.4.5 Inhibition of actin polymerization but not myosin II af-
fects the early fusion pore
The foot signal preceding single amperometric spikes [25] has attracted signif-
icant attention as it is directly related to the early fusion pore formed during
chromaffin granule exocytosis [27, 34, 58]. Neither inhibition of myosin II by
blebbistatin or ML-7 nor inhibition of actin polymerization by cytochalasin D or
latrunculin A had an effect on the mean foot current amplitude (Fig. 3.5F), sug-
gesting that neither myosin II nor actin affect the structure of the early fusion
pore. In contrast, the average foot signal duration was significantly increased
(Fig. 3.5G) by ∼65% in cytochalasin D (p < 0.0001) and latrunculin A (p < 0.05)
treated cells, but was unchanged by inhibition of myosin II with blebbistatin or
ML-7 (Fig. 3.5G). Foot signal duration could be reliably determined only for
foot signals with duration ≥5 ms and amplitude ≥1 pA. The percentage of am-
perometric spikes that had a foot signal in this range was similar for control
and blebbistatin-treated cells (33% and 35% respectively), but was increased to
45% for cytochalasin D-treated cells, consistent with the overall increase in foot
duration.
3.4.6 Alteration of fusion pore properties by cytochalasin D
Time-resolved cell-attached patch clamp capacitance measurements provide a
direct assessment of individual fusion pore properties. The data analysis (Fig.
3.6A) reveals the capacitance CV of the fused vesicle, the initial and average
fusion pore conductance, the fusion pore lifetime and the fusion pore expansion
rate [19, 21].
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Figure 3.6: (A) The real (blue trace) and imaginary (red trace) parts of the com-
plex admittance are converted into fusion pore conductanceGV (green dots) and
vesicle capacitance CV (black dots). The fusion pore initial and average conduc-
tance are depicted by the dashed horizontal black lines, while the fusion pore
expansion rate is the slope of the linear fit to the initial 15 ms segment of the
conductance trace (solid black line). The fusion pore lifetime is the time for the
conductance to reach 2 nS from its initial value. (B) Vesicle step size, (C) fusion
pore initial conductance, (D) fusion pore average conductance, (E) fusion pore
lifetime and (F) fusion pore initial expansion rate for control (CT, n = 7 cells, 86
fusion pores), blebbistatin (BL, n = 8 cells, 82 fusion pores), and cytochalasin
D-treated (CD, n = 8 cells, 78 fusion pores) cells. Data is represented as MEAN
± SEM, where n is the number of cells. Statistically significant differences (p <
0.05) are indicated by single asterisks.
Vesicle capacitance (Fig. 3.6B), as well as initial and average fusion pore con-
ductance (Fig. 3.6C & D) were unchanged in cells treated with blebbistatin or
cytochalasin D. Thus, inhibiting myosin II function or actin polymerization has
no effect on vesicle size, vesicular catecholamine concentration or early fusion
pore structure. However, inhibiting actin polymerization by cytochalasin D pro-
longed significantly the fusion pore lifetime (Fig. 3.6E) and reduced the fusion
pore expansion rate (Fig. 3.6F), explaining the observed increase in ampero-
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metric foot duration with unchanged foot current amplitude in amperometric
recordings from cytochalasin D-treated cells (Fig. 3.5F & G). This data includes
only detected fusion pores with lifetime ≥15 ms. The percentage of fusion pores
with lifetime ≥15 ms was similar for control and blebbistatin-treated cells (21%
and 30% respectively), but was increased to 51% for cytochalasin D-treated cells.
3.4.7 Distribution of foot signal durations and fusion pore life-
times
To better characterize the fusion pore kinetics, we constructed survival curves
for the detected amperometric foot signal durations (Fig. 3.7A) and fusion pore
lifetimes (Fig. 3.7B) for control, blebbistatin-treated and cytochalasin D-treated
cells. The survival curves for blebbistatin-treated cells are very similar to those
for control cells whereas increased foot duration and fusion pore lifetime is ev-
ident for cytochalasin D-treated cells. Accordingly, single exponential fits pro-
vided similar time constants τ for foot duration and fusion pore lifetimes in
control and blebbistatin-treated cells but about twice as long for cytochalasin
D-treated cells (Table 3.1).
However, single exponential fits failed to reproduce the survival curves ac-
curately, as is particularly evident in the logarithmic plots (Fig. 3.7C & D). This
indicates that the kinetics is not homogeneous but reflects an inhomogeneous
population with a distribution of rate constants. A distribution of activation en-
ergies leads to kinetics that is better described by a power law function [59, 60]:
f (t) = A
(
1 +
kt
n
)−n
(3.2)
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Figure 3.7: Linear plots of survival curves for (A) foot signal duration and (B)
fusion pore lifetime. Logarithmic plots of survival curves for (C) foot signal
duration and (D) fusion pore lifetime. A single exponential (dashed lines) and
a power law function (dotted lines) were fitted to the data. Black: control (n =
7 cells, 86 fusion pores), green: blebbistatin (n = 8 cells, 82 fusion pores), red:
cytochalasin D (n = 8 cells, 78 fusion pores).
where A is the distribution amplitude, t the time (or duration), k the rate constant
corresponding to the peak of the distribution and n corresponds to the width of
the distribution (small n indicates a broad distribution). The power law fits re-
produced the data well (Fig. 3.7, dotted lines). Table 3.1 provides the parameters
returned from the fitting procedure for each treatment group. Again, the param-
eters for blebbistatin-treated cells are very similar to those for control cells. For
cytochalasin D-treated cells the main difference is a much smaller parameter
n, which indicates a much broader distribution of rate constants, extending to
much longer foot durations and fusion pore lifetimes when actin polymeriza-
tion is inhibited.
The fraction of amperometric spikes with detectable foot signal and of fu-
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Table 3.1: Fit parameters returned for the single exponential (τ) and power law
(1/k, n) fits to the foot signal duration (amperometry) and fusion pore lifetime
(capacitance) survival curves of each treatment group.
Amperometry Capacitance
Parameter τ (ms) 1/k (ms) n τ (ms) 1/k (ms) n
Control 28.6 ± 0.4 16.4 ± 0.2 2.4 ± 0.1 13.8 ± 0.2 8.1 ± 0.7 4.7 ± 0.5
blebbistatin 28.4 ± 0.4 18.1 ± 0.2 2.8 ± 0.1 16.5 ± 0.4 7.7 ± 0.8 3.2 ± 0.3
cytochalasin D 63.8 ± 1.1 29.5 ± 0.4 1.6 ± 0.0 29.5 ± 0.7 8.8± 0.8 1.8 ± 0.1
sion pores measured by capacitance measurements with lifetime ≥15 ms was
increased in cytochalasin D-treated cells compared to control and blebbistatin-
treated cells (Table 3.2). This is consistent with the prolonged foot signal dura-
tion (Fig. 3.5G) and the increased fusion pore lifetime in cytochalasin D-treated
cells (Fig. 3.6E), which should increase the fraction of foot signals or fusion
pores longer than the detection limits of 5 ms and 15 ms, respectively. The fit-
ted data sets included only foot signals with duration ≥5 ms, and fusion pores
with lifetime ≥15 ms, since shorter durations were affected by the respective low
pass filters used and could thus not be reliably quantified. Table 3.2 compares
the fraction of amperometric spikes and fusion events that fulfilled these criteria
with the fraction of events predicted by the power law fits. While the fractions of
fusion pore lifetimes ≥15 ms are in rather good agreement with the predictions
from the power law fits, the fractions of amperometric spikes with a detectable
foot signal is much lower than the predictions of the power law fit. However,
this is not unexpected since foot signals may escape detection not only because
of short duration, but also due to small amplitude. The mean foot current am-
plitude calculated for all detected foot signals (not averaged per cell) was 3.5 ±
2.8 pA (mean ± s.d.) for control cells and similar for drug-treated cells. Since the
detection limit was 1 pA, a significant fraction of foot signals with duration >5
ms will not be detected due to small amplitude.
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Table 3.2: Comparison of percentage of detected amperometric foot signals and
capacitance fusion pores with predictions from power law fits for each treat-
ment group.
Amperometry
spikes with
detectable
foot
Expected fraction
of foot signals ≥5
ms from power law
fits
Fusion pores
with lifetime
≥15 ms
Expected fraction
of fusion pore life-
times ≥15 ms from
power law fits
Control 33% 75% 21% 23%
blebbistatin 35% 77% 30% 24%
cytochalasin D 45% 85% 51% 32%
3.5 Discussion
3.5.1 Reduced vesicular motion following inhibition of myosin
II activity
Inhibition of myosin II reduced chromaffin granule mobility, consistent with
previous reports [61, 48]. In contrast to cytochalasin D treatment, inhibition of
myosin II did not lead to reduction of cortical actin filaments, indicating that the
role of myosin II in chromaffin vesicle motion near the cell surface is not medi-
ated by disintegration of the actin-rich cortex. Although myosin motor function
is highly regulated [62], myosin activity at resting calcium concentration ap-
pears to contribute to vesicle mobility.
3.5.2 Frequency of exocytotic events
Inhibition of actin polymerization by cytochalasin D or latrunculin A led to a
66% increase in the number of exocytotic spikes consistent with the role of actin
as a physical barrier to exocytosis [45]. Blebbistatin treatment of chromaffin
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cells, however, did not result in a change of the number of measured exocytotic
spikes, consistent with the presence of normal cortical actin filaments in these
cells. In contrast, the non-specific MLCK inhibitor ML-7 reduced the number
of exocytotic events, suggesting that ML-7 inhibits exocytosis via a mechanism
that may not be mediated by inhibition of nonmuscle myosin II [63].
3.5.3 Inhibition of myosin II function or actin polymerization
slows catecholamine release during amperometric spike
phase
Inhibition of myosin II increased the average amperometric spike half-width,
consistent with experiments using chromaffin cells overexpressing an unphos-
phorylatable mutant of the myosin II RLC [48]. Inhibition of actin polymer-
ization by cytochalasin D broadened the amperometric spikes even more than
blebbistatin. Myosin II could thus exert its role via interaction with or indepen-
dent of actin. It has been suggested that tension in the vesicle membrane drives
fusion pore expansion [64] and myosin II and actin may contribute to increased
membrane tension helping to expand the fusion pore. It has so far not been pos-
sible to measure directly the fusion pore conductance in chromaffin cells during
the amperometric spike. However, fusion pore dynamics can be resolved for the
early fusion pore that gives rise to the amperometric foot signal. If F-actin and
myosin II accelerate fusion pore expansion, we would expect that this should
be reflected in the dynamics of the early fusion pore.
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3.5.4 Modulation of early fusion pore expansion by F-actin but
not myosin II activity
Indeed, inhibition of actin polymerization resulted in prolonged fusion pore
lifetimes indicated by increased amperometric foot signal durations and in-
creased narrow fusion pore lifetimes determined by cell-attached capacitance
measurements. The fusion pore expansion rate was reduced while the initial
and average fusion pore conductance as well as the average foot signal ampli-
tude were unchanged. We conclude that cortical actin does not determine the
structure of the early fusion pore, but facilitates the process of fusion pore ex-
pansion. Survival curves constructed for amperometric foot signal durations
and fusion pore lifetimes were well fitted with power laws as expected for pro-
cesses that reflect distributed kinetics based on a distribution of activation ener-
gies [59, 60, 65]. Fusion pore expansion is modulated by many factors including
Ca2+ concentration [66, 67] and PKC [68] such that a kinetic heterogeneity is not
unexpected. Inhibition of actin polymerization broadened the kinetic distribu-
tion towards longer fusion pore lifetimes providing the first direct evidence that
actin contributes to fusion pore expansion in chromaffin cells.
Inhibition of myosin II activity, on the other hand, altered neither the early
fusion pore structure, nor the fusion pore expansion rate or the early fusion pore
lifetime, suggesting that myosin II is not mediating the role of actin during the
early fusion pore. In contrast to our results, the expansion of the early fusion
pore was slower in chromaffin cells overexpressing an inactive form of myosin
II RLC [49]. One possible explanation for this apparent discrepancy would be
that blebbistatin inhibition of myosin II may be incomplete and that the residual
myosin II activity in blebbistatin-treated cells is sufficient to maintain normal
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fusion pore expansion kinetics. However, alternative explanations are at least
equally possible. In our experiments blebbistatin treatment was performed for
15 min prior to the measurements. In contrast, cells overexpressing the inactive
form of myosin II RLC were used one or more days after infection. Blebbistatin
inhibition thus reveals the immediate consequences of myosin II inhibition and
presumably its direct function in the release event. On the other hand, over-
expression experiments may in addition reveal longer term consequences. The
changes in early fusion pore expansion may reflect longer term consequences of
myosin II inhibition such as changes in vesicle maturation, docking or priming.
The two experimental approaches are thus not directly comparable and provide
complementary information.
Despite normal early fusion pore dynamics, amperometric spike half-width
was significantly increased in blebbistatin-treated cells, suggesting that the in-
creased amperometric spike half-width may not be due to slower fusion pore
expansion. It was suggested that dissociation from the granular matrix is the
major process determining amperometric spike half-width [69, 70]. The amper-
ometric spike time course shows no strong correlation with quantal size [71]
as would be expected for a rate limiting fusion pore. The time course of re-
lease of different granular contents from cytochalasin D-treated PC-12 cells was
also not correlated with the size of the particular compound, as would be ex-
pected for fusion pore limited release [72]. These results suggest that associa-
tion with and dissociation from the intragranular matrix determine the kinetics
of release. Additional support for this view came from a recent study showing
that release events from chromogranin A null mice exhibit reduced amperomet-
ric spike half-widths [73].
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3.5.5 Possible mechanisms for F-actin and myosin II function
in exocytosis
The relaxation of membrane tension exerted by actin filaments on the cell
plasma membrane in cytochalasin D-treated cells may be responsible for slower
fusion pore expansion. In contrast, inhibition of myosin II had no detectable
effect on early fusion pore expansion suggesting that actin mediates fusion pore
expansion by its interactions with other proteins.
Myosin II, however, contributes to accelerating release during the ampero-
metric spike. How can interactions of the extra-granular actin and nonmuscle
myosin II modulate catecholamine release kinetics from chromaffin granules?
Our results suggest that mechanical forces (tension) on the granules may pro-
mote dissociation from the matrix and thus expel catecholamines. It has been
proposed that in Xenopus eggs, cortical granules are compressed by F-actin dur-
ing exocytosis, contributing to the driving force for granules to secrete their
contents [74]. Nonmuscle myosin II may exert its mechanical function on chro-
maffin granules by its ability to bind and contract filamentous actin. Release
from the matrix appears to be governed by a low effective diffusion coefficient
within the matrix [75]. The change in amperometric spike width might be a
consequence of a changed effective diffusion coefficient that could result from
mechanical forces exerted on the matrix affecting its catecholamine binding in-
teractions. Alternatively it could be a consequence of a changed rate at which
the surface of the granule matrix is exposed to the extracellular medium [75]
or the size of the exposed matrix area during the rapid release phase giving
rise to the amperometric spike. However, considering that the amperometric
spike time course appears to be independent of vesicle size the latter mechanism
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would require that the rate at which the membrane surrounding the vesicle is
unwrapped or the finally exposed area is increased for larger vesicles. In either
case, the role of myosin II is likely to exert mechanical forces on the granule
by matrix compression or by expelling the matrix more rapidly, thus facilitat-
ing release by exposing the whole granule core to the extracellular solution and
accelerating dissociation from the granular matrix.
The interactions between the vesicles and the cortical actin cytoskeleton
could be mediated by myosin V, which has been localized to chromaffin gran-
ules [47], providing a possible link between an actin-myosin II scaffold and the
secretory granule. However, interactions of myosin II with chromaffin granules
should not be ruled out. The interaction of the secretory granules with actin fil-
aments appears to be mediated by localized adaptor molecules, such as N-Wasp
and ARP2/3 [76] or Rab27A and MyRip [77]. One possibility is that upon stimu-
lation the actin cortex redistributes to allow granules to collapse [78]. However,
residual polymerized actin at the immediate fusion site may persist due to lo-
calized accessory molecules allowing actin-regulating proteins, such as myosin
II to exert control on granule fusion. It thus appears possible that myosin II may
dynamically interact with actin and secretory granules via currently unidenti-
fied adaptor proteins.
3.6 Note to Chapter 3
The author is indebted to Alexis Torres who performed in their entirety the vesi-
cle tracking and the actin labeling experiments. The author would also like to
thank Dr. Qinghua Fang for the cell-attached capacitance measurements and
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Kassandra Kisler for her help with the Fura-2 measurements. The material in
Chapter 3 has been published in The Journal of Neuroscience [79].
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CHAPTER 4
IMPROVED ELECTROCHEMICAL DETECTOR ARRAYS FOR
MONITORING EXOCYTOSIS
4.1 Abstract
Surface patterned platinum microelectrodes (PtEs) insulated with 300 nm thick
fused silica were fabricated using contact photolithography. These electrodes
exhibit low noise and were used for monitoring single vesicle exocytosis from
chromaffin cells by constant potential amperometry as well as fast scan cyclic
voltammetry. Amperometric spike parameters were consistent with those
obtained with conventional carbon fiber electrodes (CFEs). Catecholamine
voltammograms acquired with PtEs exhibited redox peaks with full width at
half maximum of ∼45 mV , much sharper than those of CFE recordings. The time
course of voltammetrically measured release events was similar for PtEs and
CFEs. The fused silica insulated PtEs could be cleaned and reused repetitively
and allowed incorporation of micrometer precision surface patterned poly-D-
lysine (PDL). PDL-functionalized devices were applied to stimulate mast cells
and record single release events without serotonin pre-loading. Microfabricated
PtEs are thus able to record single exocytotic events with high resolution and
should be suitable for highly parallel electrode arrays allowing simultaneous
measurements of single events from multiple cells.
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4.2 Introduction
Exocytosis is a fundamental cellular mechanism by which cells extrude the con-
tents of membrane bound vesicles into the extracellular space. Many techniques
have been employed to investigate single exocytotic events including whole
cell patch clamp capacitance measurements [17, 16, 19, 18], cell attached ca-
pacitance measurements [21, 22, 23, 20], carbon fiber amperometry [24, 25, 26],
patch amperometry [27, 28, 29], and total internal reflection fluorescence micro-
copy [11, 12, 13, 14, 15].
The probably most widely used method for the study of single exocy-
totic events utilizes a CFE [36], which records the release of oxidizable com-
pounds, such as catecholamine release from chromaffin cells [24, 25, 26] or even
dopamine release from dopaminergic neurons [80, 81, 82, 83] at extraordinary
resolution. Low noise and high temporal resolution have been achieved, due to
the CFE’s small size and fast response time.
There are, however, two limitations to the CFE technique: (i) To obtain sta-
tistical significance, experiments need to be performed on a large number of
cells [84, 56], which is time consuming for single cell experiments under a micro-
scope, and (ii) the simultaneous electrochemical detection of release and fluores-
cence imaging of the same vesicle is not readily possible. Fluorescence imaging
can often provide important complementary information on vesicle motion [15]
or molecular events associated with vesicle exocytosis [30].
To overcome this limitation, surface patterned electrochemical microelec-
trodes have recently been fabricated using platinum (Pt) [41, 42] or indium-tin-
oxide (ITO) [85, 86] as the working electrode material. Here, we describe an
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improved design of reusable surface-patterned, glass insulated platinum elec-
trodes (PtEs) and characterize their properties in amperometric as well as fast-
scan cyclic voltammetric modes for their use in the study of single exocytotic
events.
4.3 Materials and methods
4.3.1 Cell preparation, reagents and solutions
Bovine chromaffin cells were cultured on 8 mm glass coverslips as described [50].
Mast cells were isolated from the peritoneum of adult Sprague-Dawley rats
as described [87]. The solution used for all electrochemical recordings con-
tained (in mM) 140 NaCl, 5 KCl, 5 CaCl2, 1 MgCl2, 10 HEPES/NaOH, 20 glu-
cose (pH 7.3). Dopamine hydrochloride, (±)-Epinephrine hydrochloride, DL-
Norepinephrine hydrochloride, and Poly-D-Lysine (PDL) were all purchased
from Sigma (Milwaukee, WI) and used without further purification. Experi-
ments were performed at room temperature, at day 1 after isolation for chro-
maffin cells and at the day of isolation for mast cells.
4.3.2 CFE fabrication
CFEs were fabricated as described [24]. Briefly, a single carbon fiber (5.0 µm
diameter) was inserted in a borosilicate glass capillary (1.8 mm outer diameter,
Hilgenberg GmbH, Germany). The capillary was then pulled using a pipette
puller (Model P-97, Sutter instrument) producing two CFEs, which were sepa-
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rated with scissors. CFE tips were dipped in melting wax (Sticky Wax, Kerr Cor-
poration) for 2 min and subsequently cut using a blade (No 10, Feather Safety
Razor Co, Japan). Prior to experiments, CFEs were backfilled with 3 M KCl
solution.
4.3.3 PtE microfabrication
Single, triple, or quadruple PtEs were surface patterned on 4” diameter borosili-
cate glass wafers of thickness 160-190 µm (ThermoFisher Scientific, Portsmouth,
NH) using contact photolithography techniques and metal lift-off using the fol-
lowing protocol:
1. Clean the wafer by rinsing with acetone while the wafer is spinning.
2. Bake the wafer on a hotplate for ∼3 min at 115oC. This step enhances the
effectiveness of the vapor priming (next step).
3. Vapor prime the wafer surface with hexamethyldisilazane (HMDS) in a
YES LP-III (Yield Engineering Systems, Inc., Livermore, CA) oven.
4. Spin coat the wafer with Shipley S1813 photoresist. Spin the wafer at 4,000
rpm for 30 s (ramp up at 10,000 rpm/s, ramp down at 2,000 rpm/s for 2 s).
5. Soft bake the wafer on a hotplate at 115oC for 1 min.
6. Place the wafer in a contact aligner (i.e. EV620, EV Group, Scha¨rding,
Austria). Use the metal layer mask to selectively expose the photoresist to
UV light.
7. Bake the wafer on a hotplate for 2.5 min at 115oC (post-exposure bake).
8. Bake the wafer with NH3 in a YES oven (image reversal).
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9. Expose the entire wafer to UV light for 60 s using a contact aligner.
10. Develop the photoresist in AZ c©300MIF for 1 min. 300 MIF is a positive-
photoresist developer, which contains 2.38% by weight tetramethyl am-
monium hydroxide (TMAH).
11. Descum the photoresist using O2 plasma clean for 30 s with PT 72 (Plasma
Therm Inc., Kresson, NJ).
12. Place the wafer in an evaporator, deposit 5 nm of the desired adhesion
layer metal (either Cr or Ti) at a ∼1 Å/s deposition rate. After depositing
the adhesion layer, evaporate 150 nm of Pt at a ∼5 Å/s deposition rate.
13. Place the wafer upside down in a beaker containing the Microposit re-
mover 1165 (Shipley Co Inc, Austin, TX) and set aside for a few hours
for the photoresist to come off (metal lift-off). Rinse the wafer thoroughly
with isopropanol while removing from the beaker, to avoid metal sheets
from sticking on the electrodes.
14. Remove the wafer from the beaker and rinse with methanol.
15. Deposit 300 nm of SiO2 using a plasma-enhanced chemical vapor depo-
sition (PECVD) system (IPE 1000). Use silane (SiH4) and nitrous oxide
(N2O), keeping chamber temperature to 240oC. These conditions should
result in a SiO2 deposition rate of ∼40 nm/min.
16. Vapor prime the wafer surface with HMDS as above.
17. Spin coat the wafer with S1813 photoresist as above.
18. Soft bake the wafer on a hotplate at 115oC for 1 min.
19. Place the wafer in a contact aligner (i.e. EV620 as above), and expose to
UV light after aligning the insulation layer mask with the metal that has
already been deposited onto the wafer.
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20. Bake the wafer on a hotplate for 2.5 min at 115oC (post exposure bake).
21. Develop the photoresist using 300 MIF as above.
22. Descum the photoresist as above.
23. Hard bake the wafer on a hotplate for 5 min at 115oC in order to harden the
photoresist, such that it will not easily etch during the next step.
24. Etch the SiO2 using trifluoromethane (CHF3) and oxygen (O2) at a ratio of
50 sccm/2 sccm. The Oxford 80 (PlasmaLab 80+, Oxford Instruments, Ox-
fordshire, UK) can be used for this step. The etching should be performed
for ∼ 12 min (consult updated etching rates for the instrument).
25. To remove the remaining photoresist, place the wafer in a beaker contain-
ing nanostrip: sulfuric acid (H2SO4) and hydrogen peroxide (H2O2). In
some cases it will be necessary to use q-tips to gently remove the photore-
sist from the wafer.
26. Cut wafer into 2.5x2.5 cm2 pieces using a wafer saw.
A photograph of a coverslip containing PtEs is shown in Fig. 4.1.
4.3.4 Chemical functionalization
For mast cell recordings, coverslips with microfabricated PtE arrays were coated
with ∼1 µm thick Parylene-C using a Model PDS 2010 Labcoter (Specialty Coat-
ing Systems, Indianapolis, IN), followed by spin coating of ∼1.3 µm thick S1813
photoresist. A 5 µm diameter circular region of the photoresist at the center of
the PtE array or next to a single PtE was removed using standard photolithogra-
phy techniques, and the exposed Parylene was etched with a reactive ion etcher
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Figure 4.1: A photograph of a coverslip containing four PtE arrays, each con-
taining four electrodes. Photo: courtesy of O.D. Escanilla.
(PlasmaTherm 72). 10 µL of 0.1% PDL in distilled water was applied to the sur-
face (Fig. 4.2A), after allowing 1 h for surface coating the unbound PDL was
washed off with distilled water. The coverslips were dried at room temperature
for 15 min and stored overnight at 4oC after which the Parylene was carefully
removed using tweezers. Thus, the PtE array center was selectively coated with
PDL (Fig. 4.2B). Prior to the electrochemical recordings, ∼100 µL of freshly iso-
lated mast cell suspension was added via a pipette onto the coverslips.
4.3.5 Amperometry
Coverslips containing the electrochemical detectors were mounted on a custom
built stage for a Zeiss 135TV microscope. Platinum electrodes were connected
to the amplifiers via spring loaded gold contact pins and individual cells were
placed on the electrodes as described [41, 42]. Amperometry was performed
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Figure 4.2: Schematic of the surface patterning of PDL on the PtE arrays before
(A) and after (B) dry lift-off.
with a four-channel amplifier (VA-10, NPI Electronic, Tamm, Germany). The
measured current was low pass filtered at 100 Hz using the built-in analog low
pass filter of the VA-10 amplifier. The electrodes were held at +700 mV versus
an Ag|AgCl wire immersed into the bath solution. Amperometric data was dig-
itized at 2 kHz sampling rate using a 16-bit resolution analog-to-digital (A/D)
converter (BNC-2090, NIDAQ, National Instruments, Austin, TX). If necessary,
line frequency noise was removed by fitting a sine wave (baseline, amplitude,
frequency and phase) to portions of the recordings without any amperometric
spikes and subsequently subtracting the resulting sine wave from the data [41].
Amperometric spike parameters were extracted as described [56] using proce-
dures written in Igor Pro. The criteria used for identifying amperometric spikes
were 10 pA minimum amplitude and 100 ms maximum half-width. The thresh-
olds used for identifying foot signals were 1 pA amplitude and 5 ms duration.
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4.3.6 Fast-scan cyclic voltammetry
Fast-scan cyclic voltammetry was performed with an EPC-8 patch-clamp ampli-
fier (HEKA-Elektronik, Lambrecht, Germany). The amplifier’s built-in analog
low pass filter was set to 5 kHz. The standard voltage waveform applied to the
working PtE versus the reference Ag|AgCl wire consisted of a 10 ms triangu-
lar segment, during which the electrode voltage was scanned from -500 mV to
+1,000 mV and back to -500 mV at a rate of ±300 V/s. The triangular segment
was followed by a 90 ms resting period during which the electrode potential
was held constant at -500 mV . For experiments at increased time resolution (see
Results) the duration of the resting period was reduced to 15 ms and the ramp
speed was doubled to ±600 V/s, while the resting and peak potentials remained
unaltered. Voltammetric currents were digitized at a rate of 25 kHz using a 16-
bit A/D converter (ITC-18, Instrutech Corp, Bellmore, NY), and analyzed using
procedures written in Igor Pro [88].
4.4 Results
4.4.1 Chromaffin cell amperometry
Fig. 4.3A shows an electron microscope (Zeiss Supra 55VP) image of a 3-
electrode PtE array insulated with SiO2. The oxide layer is highly uniform and
homogenous. Bovine chromaffin cells were placed on top of PtE arrays using a
patch pipette as described [41, 42]. The placement procedure stimulated exocy-
totic catecholamine release which was recorded by the PtE array.
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Figure 4.3: (A) Electron microscope image of a PtE array immediately after fab-
rication. Scale bar: 1 µm. (B) A characteristic amperometric recording from the
3-electrode Pt array of (A). Different colors represent signals measured by dif-
ferent electrodes in the array. (C) The exocytotic event indicated by the arrow in
(B) is shown on an expanded time scale. The inset shows the integrated traces
which correspond to the charges measured by each electrode. (D) Four differ-
ent exocytotic events from the recording in (B). (E) Electron microscope image
of the same PtE array as in (A) after multiple single cell experiments and alcohol
cleanings. Scale bar: 1 µm.
Fig. 4.3B shows an amperometric recording with this 3-electrode array from
a chromaffin cell that produced more than 100 exocytotic events, many of which
were detected by multiple electrodes. From the total of 138 identified events of
this recording, 102 were detected by at least two electrodes and 55 by all three
electrodes. Employing multiple electrodes allows for spatial localization of the
individual exocytotic events provided that amperometric signals are detected
by at least three electrodes [42].
Fig. 4.3C shows on an expanded time scale the single amperometric event
indicated by the arrow in Fig. 4.3B. The inset of Fig. 4.3C shows the running in-
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tegrals of the current traces, which indicate the time course of measured charge
by each electrode. The sum of the final values of the three integrated traces cor-
responds to the vesicle quantal size, which for this particular event is 6.9 pC or
∼21.6 million molecules.
Four distinct events from the recording of Fig. 4.3B are shown on an ex-
panded time scale in Fig. 4.3D. These events have short half-widths and signifi-
cantly different foot signal time courses, demonstrating that PtEs can closely fol-
low the time course of catecholamine release from individual chromaffin gran-
ules. To quantify the performance of microfabricated PtEs, the amperometric
spikes were analyzed as described [56] for quantal size, half-width, foot signal
duration and foot signal mean amplitude. Quantal size was measured as the
sum of charges detected by all electrodes. The three other parameters were de-
rived from the amperometric spike measured by the electrode located closest to
the release site (shortest half-width).
The averaged quantal size was 1.82 ± 0.15 pC and the averaged half-width
13.8 ± 0.6 ms (mean ± sem, n = 138 events). Out of the total of 138 individual
spikes, 90 had detectable foot signals (65%), with average foot signal duration
11.1 ± 3.7 ms and foot signal mean amplitude of 4.0 ± 0.4 pA (mean ± sem, n
= 90 events). The averaged values of the four parameters are similar to those
reported for CFEs [25, 89].
To determine the PtE noise, the stored current traces were examined at 1 s
segments which did not contain any amperometric spikes. The measured stan-
dard deviation of the noise was 75 ± 15 f A (mean ± sd, n = 3 electrodes, ∆ f = 100
Hz), indistinguishable from the amplifier’s feedback resistor (500 MΩ) Johnson
noise, which was measured to be 65 f A with the head stage in the open circuit
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configuration. The measured noise did not differ significantly from the theoreti-
cally expected noise level σI , which can be calculated as σI =
√
4kT∆ f
R [37], where
k is the Boltzmann constant, T the temperature in degrees K, ∆ f the low-pass
filter’s cutoff frequency, and R the feedback resistor’s resistance value.
In addition to low current noise, the SiO2-insulated PtEs were mechani-
cally and chemically robust, since multiple single cell experiments followed by
ethanol cleaning of the PtE coverslips did not damage the electrodes (compare
Fig. 4.3A & E).
4.4.2 Mast cell amperometry
In contrast to excitable cells, exocytosis of mast cells is not mediated by ion
channel activation, but by chemical signaling [90]. To determine if PtEs can be
utilized to record exocytosis from rat peritoneal mast (RPM) cells, PtEs were
functionalized with PDL, an established activator of RPM cell exocytosis [91].
A 5 µm diameter circular region at the center of the PtE array was selec-
tively coated with PDL using the dry lift-off technique [92] (see Materials and
Methods). A single RPM cell (Fig. 4.4A) was lifted with a glass micropipette
and manipulated on top of a single PtE (Fig. 4.4B), the area in front of which
was previously coated with PDL (Fig. 4.4C). Shortly after placement on top of
the electrode, the cell degranulated and a series of amperometric events was
recorded by the PtE (Fig. 4.4D). Amperometric events with quantal size as low
as 9.5 fC were resolved, corresponding to the measurement of ∼14,800 sero-
tonin molecules, since electrochemical oxidation of serotonin results in the do-
nation of four electrons per molecule [93]. PtEs can thus measure very small
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Figure 4.4: (A) A peritoneal mast cell. Scale bar: 5 µm. (B) The mast cell of (A) on
top of a single PtE. (C) Different regions indicated by numbers. 1: SiO2 insulated
part of Pt conductor, 2: PDL coated area, 3: exposed area forming the active PtE,
4: All the area outside the large circle including area 1 is covered with the SiO2
insulation layer. (D) The corresponding amperometric recording from the cell
shown in (B).
amounts of electroactive compounds.
From twelve mast cells placed on top of two different PtE arrays that were
not functionalized with PDL, only two amperometric spikes were recorded. The
functionality of the PtE arrays was subsequently verified using catecholamine
solutions. This indicated that unlike chromaffin cells, mast cells were not stim-
ulated by the mechanical placement procedure.
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4.4.3 Fast-scan cyclic voltammetry
While constant potential amperometry can measure single vesicle release with
high resolution, it does not allow identification of the detected compound. Such
identification is, however, possible using fast scan cyclic voltammetry (FSCV),
as demonstrated for CFE detection of catecholamines [94, 24, 95].
To determine if microfabricated PtEs can also be utilized as the working elec-
trodes for FSCV, the potential waveform shown in the inset of Fig. 4.5 was ap-
plied to the PtEs. In physiological saline the resulting current during the voltage
ramps is largely due to charging of the double layer capacitance, and is known
as the background current. In the presence of electrochemically active com-
pounds in the buffer solution, the resulting current consists of the background
current plus a faradaic current due to the redox reactions at the electrode sur-
face [38]. Subtraction of the background current results in the difference cur-
rent, which when plotted versus the applied potential gives the background-
subtracted voltammogram. The background-subtracted voltammograms for
the catecholamines DA, norepinephrine (NE) and epinephrine (EPI) contain
two peaks, one at positive potential due to oxidation of the catecholamine to
its quinone form, and a second at negative potential due to reduction of the
quinone back to the original catecholamine [96].
For the background-subtracted voltammogram it is essential that the back-
ground current is stable between successive measurements. For three electrodes
of 10 µm2 active area the current at +160mV applied potential of the anodic ramp
was monitored for 10 s segments and the measured standard deviation was 8
± 2 pA (mean ± sd, n = 3 electrodes, ∆ f = 5 kHz), which does not exceed the
Johnson noise of the amplifier’s feedback resistor and the A/D converter quan-
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Figure 4.5: In vitro background subtracted voltammograms obtained from PtEs
after addition of 1 µM DA, NE or EPI respectively. Inset: potential waveform
applied to the PtEs.
tization error (∼6 pA). The background current of SiO2-insulated PtEs was thus
very stable between successive voltammetric measurements.
In vitro calibrations of PtEs using 1 µM concentrations of the catecholamines
DA, NE and EPI resulted in similar background-subtracted voltammograms
for all three compounds (Fig. 4.5). The voltage waveform of Fig. 4.5 (inset)
was chosen because the negative resting potential promoted adsorption of cat-
echolamines onto the Pt surface, in a fashion similar to that for CFEs [97].
In several cases it was not possible to remove the catecholamines from the
PtE surfaces such that catecholamine voltammograms remained detectable in
plain buffer even after washing the PtEs with alcohol, distilled water, or oxygen
plasma clean. This is presumably due to adsorption of catecholamines on the
PtEs [98]. The adsorbed catecholamines were only removed from the electrode
surfaces when 0.18 M H2SO4 was added onto the PtEs and the electrode poten-
tial was scanned at a rate of 100 mV/s between -500 mV and +975 mV . In some
cases it was necessary to perform this electrochemical cleaning for up to 1 h,
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until the cyclic voltammogram of a pure Pt surface was detected [38].
In addition to the difficulty of removing the catecholamines from the PtE
surfaces, some PtEs did not produce a catecholamine voltammogram as shown
in Fig. 4.5, although their functionality was verified via amperometric detection
of catecholamines. The reasons for this malfunction remain elusive.
4.4.4 Chromaffin cell voltammetry
To test if PtEs could detect cellular release events in FSCV mode, individual
chromaffin cells were placed on top of single PtEs (Fig. 4.6) while the voltage
waveform of Fig. 4.7A (inset) was applied to the PtE. As in amperometry, the
placement procedure stimulated the cells and voltammetric spikes indicating
chromaffin vesicle exocytosis [24] were observed. The time course of the current
sampled at the +230 mV applied potential of the anodic ramp is shown in Fig.
4.7A for successive sweeps.
Figure 4.6: A single chromaffin cell (middle) placed via a pulled glass pipette
(left) on top of a PtE (right).
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Fig. 4.7B shows the background current (dashed black trace, corresponding
in time to the arrow marked a in Fig. 4.7A), the background plus faradaic cur-
rent (solid red trace, corresponding in time to the arrow marked b in Fig. 4.7A),
as well as their difference (solid blue trace). The difference current was plotted
versus the applied potential and revealed the signature voltammogram of cat-
echolamine molecules (Fig. 4.7C), with two peaks, the first at +230 mV of the
anodic ramp and the second at -260 mV of the cathodic ramp. As is the case
with CFEs [88], the redox peaks of Pt difference voltammograms consistently
occurred at slightly different potentials in single cell experiments (Fig. 4.7C)
compared to in vitro calibrations (Fig. 4.5).
The background current of the PtE was very stable, such that no sweep av-
eraging was necessary to obtain the voltammograms. We conclude that SiO2-
insulated PtEs are suitable for low-noise FSCV applications to measure exocy-
totic release of oxidizable transmitter molecules.
4.4.5 PtE versus CFE voltammetry
Fig. 4.8A compares catecholamine voltammograms measured during release
from single chromaffin cells with a PtE (black) and a CFE (red) after normaliz-
ing to their respective peak oxidation currents. The voltammograms obtained
with CFEs are in good agreement with those previously reported [99, 88], with
oxidation/reduction peaks at +435 mV and -350 mV respectively.
In contrast, the peaks for the Pt voltammogram are shifted to approximately
+230 mV and -260 mV for oxidation and reduction respectively. Interestingly, the
full width at half maximum (FWHM) of the oxidation peaks of voltammograms
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Figure 4.7: (A) Catecholamine release indicated as current spikes recorded by a
PtE. The current was sampled at the +230 mV applied potential of the anodic
ramp. The average value of the first 10 cycles was subtracted from the current
trace. The inset shows the applied potential waveform. The red dot indicates
the voltage at which the current was sampled (+230 mV of the anodic ramp). (B)
Background (dashed black trace, corresponding to the vertical arrow marked a
in panel (A)), background plus faradaic (solid red trace, corresponding to the
vertical arrow marked b in panel (A)), and their difference (blue trace). (C) The
difference current plotted versus the applied potential reveals the voltammo-
gram for catecholamine molecules with an oxidation peak at +230 mV and a
reduction peak at -260 mV .
obtained with PtEs was ∼45 mV , which corresponds to the Nernstian limit for a
2-electron transfer reaction [38], indicating very rapid catecholamine oxidation.
The FWHM for the CFE oxidation peak was ∼310 mV , ∼7-fold larger than the
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Figure 4.8: (A) Typical cyclic voltammograms normalized to their peak oxi-
dation values, obtained from chromaffin cells using either Pt microelectrodes
(black) or CFEs (red). (B) Time course of voltammetric spikes for Pt (black) and
CFE (red). Curves are the average of 20 individual spikes measured with 20 ms
time resolution using the voltage waveform shown in the inset.
corresponding value for Pt, which can be accounted for by the greater density
of states of Pt compared to carbon [100].
Another interesting characteristic of catecholamine voltammograms is that
the reduction peak is usually significantly smaller than the oxidation peak, pre-
sumably due to diffusion of the oxidized quinone away from the electrode sur-
face. For the voltammograms of Fig. 4.8A, the reduction peak measured with
PtEs was ∼73% of the oxidation peak, while the reduction peak was decreased
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to ∼55% of the oxidation peak for the CFE.
The higher reduction to oxidation ratio suggests stronger adsorption of cat-
echolamines onto PtEs [98] compared to CFEs. To determine if this affects the
time course of voltammetric spikes we compared single events measured with
CFEs and PtEs. For increased time resolution the resting period of the applied
potential waveform was reduced to 15 ms and the ramp speed was increased
to ±600 V/s resulting in a voltage waveform of 20 ms total duration and thus a
higher temporal resolution for the FSCV measurements (Fig. 4.8B inset).
Using this waveform, single exocytotic events were recorded using PtEs and
CFEs. The half-widths of voltammetrically measured spikes are determined
not only by the granule secretion time course, but also by the diffusion of the
catecholamine molecules away from the electrode surface and the low tempo-
ral resolution of the measurements (20 ms). Fig. 4.8B shows the average time
course of the 20 largest voltammetric spikes recorded with PtEs or CFEs. For
this purpose, spikes were normalized to their peak amplitude, aligned in time
at the point of their maximum value and averaged. The average time course
appears to be slightly faster for PtEs. However, the measured mean half-width
of voltammetric spikes from chromaffin cells was 56 ± 5 ms (mean ± sem, n =
59 spikes) for PtEs and 71 ±11 ms (mean ± sem, n = 31 spikes) for CFEs was not
significantly different (p = 0.17). The value obtained with CFEs is in excellent
agreement with data reported in the literature [39].
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4.5 Discussion
The electrode of choice for electrochemical recordings from biological cells has
traditionally been the carbon fiber electrode [101]. Recently, however, Au was
utilized as the working electrode in catecholamine measurements in vitro [102],
while recordings of transmitter release from single chromaffin vesicles were per-
formed using Pt working electrodes [41, 42].
Microfabricated PtE arrays [41] can correlate amperometric and fluorescence
measurements corresponding to the same single exocytotic event [42]. Here, we
described an improved design of the PtE arrays and its application in FSCV
recordings and stimulus-secretion coupling.
Insulating the PtE arrays with fused silica (SiO2) increases the robustness of
the devices (compare Fig. 4.2A & E) allowing cleaning and multiple use, thus
reducing electrode fabrication time and cost. Contrary to photoresist, SiO2 insu-
lation does not exhibit autofluorescence, which improves sensitive fluorescence
measurements. Furthermore, our sensor’s low electrical noise, as demonstrated
in the present study, makes it suitable for electrochemical monitoring of exo-
cytosis in cell systems that release small number of electroactive molecules per
vesicle, such as mast cells or dopaminergic neurons.
The SiO2 insulation makes it furthermore possible to incorporate surface
patterned stimuli for the study of stimulus-secretion coupling. RPM cells can
be stimulated by a chemical cue patterned with micrometer spatial resolu-
tion [103]. Here, we show that this can be combined with secretion measure-
ments using SiO2 insulated PtEs.
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PtE arrays may also be used for parallel recording by multiple cells at the sin-
gle cell level, particularly utilizing newly developed low-noise amplifiers [104]
which can be integrated with the PtE arrays. The FSCV experiments indicate
that SiO2-insulated Pt microelectrodes exhibit stable background currents and
the catecholamine cyclic voltammograms are much sharper than those mea-
sured with CFEs. They are thus suitable for analytical electrochemistry in cell
cultures and possibly in vivo [8], after fabrication of appropriately shaped Pt
microelectrodes [105].
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CHAPTER 5
RANDOM WALK SIMULATIONS FOR THE STUDY OF
CATECHOLAMINE RELEASE AND DIFFUSION
5.1 Abstract
Electrochemical detector arrays were utilized in amperometric measurements
of exocytotic catecholamine release from individual chromaffin vesicles. The
signals measured by individual electrodes were compared with random walk
simulations to obtain information about the spatiotemporal dynamics of single
vesicle release. For an individual release event, different electrodes in the array
detected different amperometric spike shapes corresponding to the same secre-
tory event due to the different release site-electrode distances. A comparison
between the measured and the simulated charges for the different electrodes re-
vealed the positions of the release events. The time courses of catecholamine re-
lease from the vesicles and diffusion from the release site to the measuring elec-
trodes were determined by simultaneously fitting the simulated time courses
to the amperometric spikes measured by the individual electrodes. The results
indicate that the time courses of catecholamine diffusion towards the electrodes
were significantly slower than what would be expected for free catecholamine
diffusion in an aqueous buffer. The slow diffusion rates were presumably due
to reversible binding of catecholamines on the cell membrane, as indicated by
random walk simulations incorporating such interactions with the cell surface.
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5.2 Introduction
Neurotransmitter release by secretory vesicles, also known as exocytosis [2], is
a fundamental biological process found in many cell types. Chromaffin cells
of the adrenal gland constitute a widely used model system to study neuronal
exocytosis. Chromaffin granules secrete high amounts of catecholamines, which
can be electrochemically monitored with a carbon fiber electrode (CFE) [106, 24]
using either amperometry or fast-scan cyclic voltammetry (FSCV) [94, 95].
Amperometric detection of individual exocytotic events using a CFE re-
sults in current spikes, which reflect the convolution of the time course of cate-
cholamine release R(t) with the time course of diffusion D(t) from the release site
to the CFE [75, 107, 25, 69, 24]. For a single CFE placed closely to the cell mem-
brane and assuming instantaneous vesicular release, the catecholamine diffu-
sion has been modeled as a one-dimensional random walk to produce an an-
alytical solution for the time course of the measured amperometric spike [25].
However, measurements with variable cell-electrode distances indicated that
release is not instantaneous [89], which may be due to slow dissociation of cat-
echolamines from the granular matrix [69, 73], limited exposure of the granule
matrix to the extracellular medium [75] or both. In measurements with a single
CFE it is not possible to distinguish clearly the time course of release from the
time course of diffusion because the distance between the release site and the
recording electrode cannot be determined for individual events.
Microfabricated electrochemical detector (ECD) arrays overcome this limi-
tation by simultaneous measurements with multiple electrodes that are located
at different distances from the release site [41, 42]. Depending on their position
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relative to the release site, the individual electrodes detect different fractions of
the released molecules and the molecules reach the different electrodes with dif-
ferent diffusion time courses. Using a time-domain deconvolution of ECD array
amperometric data, the true time course of catecholamine release from individ-
ual granules R(t) and the time course of catecholamine diffusion D(t) from the
release site to the individual electrodes can be distinguished.
5.3 Materials and methods
5.3.1 Cell preparation and solutions
Bovine chromaffin cells were prepared as previously described [50]. The
buffered solution used for all the amperometric and voltammetric measure-
ments contained (in mM) 140 NaCl, 5 KCl, 5 CaCl2, 1 MgCl2, 10 HEPES/NaOH,
20 glucose (pH 7.3). Cells were stimulated using a glass micropipette containing
(in mM): 45 NaCl, 100 KCl, 5 CaCl2, 1 MgCl2, 10 HEPES/NaOH, 20 glucose (pH
7.3).
5.3.2 ECD array microfabrication
The microfabrication process for the ECD arrays was as described [41]. Briefly,
contact photolithography techniques were utilized to pattern platinum elec-
trode arrays on glass coverslips, and insulate them with a thin (∼ 500 nm) layer
of photoresist. Four electrodes converged in a ∼ 10 µm2 area, where the insula-
tion free electrode tips were exposed forming the active detectors.
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5.3.3 Carbon fiber electrode fabrication
Carbon fiber electrodes were fabricated as described [24]. Briefly, a single carbon
fiber (∼5 µm diameter) was inserted in a borosilicate glass capillary (1.8 mm outer
diameter, Hilgenberg GmbH, Germany). The capillary was then pulled using a
pipette puller (Model P-97, Sutter instrument) producing two electrodes, which
were separated with scissors. CFE tips were dipped in melting wax (StickyWax,
Kerr Corporation) for 2 min and subsequently cut using a blade (No 10, Feather
Safety 55 Razor Co, Japan). Immediately prior to experiments, electrodes were
backfilled with 3 M KCl solution and a chlorinated silver wire (Ag|AgCl) was
inserted in the glass pipette to make a connection with the amplifier.
5.3.4 ECD array amperometry
Coverslips containing the ECD arrays were mounted on a custom built stage for
a Zeiss 135TV microscope. Platinum electrodes were connected to the amplifiers
via spring loaded gold contact pins and individual cells placed on the electrodes
as described [41, 42]. Amperometry was performed with a four-channel ampli-
fier (VA-10, NPI Electronic, Tamm, Germany). The measured current was low
pass filtered at 500 Hz using the built-in analog low pass filter of the VA-10 am-
plifier. The electrodes were held at +700 mV versus a Ag|AgCl wire immersed
into the bath solution. Amperometric data were digitized at 2 kHz sampling rate
using a 16-bit resolution analog-to-digital (A/D) converter (BNC-2090, NIDAQ,
National Instruments, Austin, TX, USA). Experiments were performed at room
temperature the first day following chromaffin cell isolation.
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5.3.5 CFE fast-scan cyclic voltammetry
Fast-scan cyclic voltammetry was performed using a CFE connected to an EPC-
8 patch-clamp amplifier (HEKA-Elektronik, Germany). The corner frequency of
the amplifier’s built-in analog low pass filter was set to 5 kHz. The voltage wave-
form applied to the working CFE versus the reference Ag|AgCl wire consisted
of a 5 ms triangular segment, during which the electrode voltage was scanned
from -500 mV to +1,000 mV and back to -500 mV at a rate of ±600 V/s respectively.
The triangular segment was followed by a 15 ms resting period during which
the electrode potential was constant at -500 mV . Voltammetric currents were
digitized at a rate of 50 kHz using a 16-bit A/D converter (ITC-18, Instrutech
Corp, Bellmore, NY, USA). Experiments were performed at room temperature
at day 1 following cell isolation.
5.3.6 Random walk simulations and data analysis
Random walk simulations were performed with custom written software in the
Java programming language, using FORTE CE 3.0 for Java (Sun Microsystems,
Santa Clara, CA). The fitting algorithms and the data analysis software were
developed using Igor Pro (WaveMetrics Inc., Lake Oswego, OR, USA).
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5.4 Results
5.4.1 Random walk simulations of ECD array amperometry
The ECD arrays utilized here consist of four surface-patterned Pt electrodes on
a glass coverslip [41, 42]. For amperometric recordings, a single chromaffin cell
is placed on top of the ECD array with a glass micropipette [41]. The placement
procedure stimulates exocytotic activity in the cells presumably by inducing
Ca2+ entry into the cells. Catecholamine molecules released from single vesi-
cles diffuse in the narrow space between the cell surface and the ECD array,
bouncing off the cell membrane and the glass coverslip. For this irregular ge-
ometry, there is no analytical solution for the diffusion equation, therefore the
catecholamine diffusion was modeled as a random walk [43, 108].
For the random walk simulation (RWS) of diffusion from a specific site on
the cell surface, the cell is modeled as a semi-infinite impermeable cylinder lo-
cated ZCD distance away from the ECD array plane, and its center C(0, 0, 0) is
taken as the origin of the coordinate system (Fig. 5.1A). The release location
(x0, y0, 0) on the cell surface, the number N of released catecholamines, the cell-
detector vertical distance ZCD, and the diffusion constant D are all user-defined
parameters.
In the simulations, diffusion of each released molecule is tracked until one
of the three following conditions is met: (i) the molecule touches an electrode
surface, (ii) a user-defined time is elapsed from the beginning of the simulation,
or (iii) the molecule has diffused more than 10 µm away from the cell center C.
In case (i) the molecule is oxidized, while in cases (ii) and (iii) the molecule is
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Figure 5.1: (A) Schematic of the geometry used for the RWS. The cell is mod-
eled as an impermeable cylinder sitting on top of the ECD array coverslip
(white) which contains the active electrodes (black). (B) RWS for N = 1, 000, 000
molecules released from the cell center located directly in front of a single 5x5
µm2 electrode (shown in inset), with D = 600 µm2/s and ZCD = 0.5 µm. Superim-
posed are the curves corresponding to the two methods described in the text:
constant L (black curve), and variable L (red curve).
considered lost. When it encounters the glass coverslip a molecule is bounced
off. The molecule is also bounced off the cell membrane. The red trace of Fig.
1A shows the random walk of a representative molecule released from the cell
center, which bounces off from the coverslip (white) and gets oxidized at an
electrode’s surface (black).
The simulation time step ∆t is a critical parameter for the RWS. Too large
values of ∆t produce inaccurate diffusion time courses, whereas too small values
of ∆t result in extremely long computation times. We have chosen to set the
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simulation time step ∆t equal to the largest power of 10 for which:
∆t ≤ (sZCD)
2
6D
(5.1)
where the scaling factor s was set equal to 0.3 for all the simulations, because
smaller values did not improve the simulation results. The simulation time step
∆t obtained from equation (5.1) satisfies the requirement to be small compared
to the time necessary for molecules to diffuse across the cell-detector vertical
distance ZCD.
The average diffusion distance ∆L per time step ∆t is given by the three-
dimensional Einstein-Smolochowski equation:
∆L =
√
6D∆t (5.2)
After each time step, a molecule located at (x, y, z) is assigned a new position
(x + ∆x, y + ∆y, z + ∆z). Critical to the RWS are the diffusion steps (∆x,∆y,∆z).
These steps have a normal distribution [108]. To obtain three normally dis-
tributed random numbers with zero mean and variance σ2 = 2D∆t, such that
∆L =
√
∆x2 + ∆y2 + ∆z2 satisfies equation (5.2) the polar form of the Box-Muller
transform [109] was utilized. The resulting time course is shown in Fig. 5.1B
(red trace). However, obtaining three normally distributed random numbers
per time step and for each molecule requires a large amount of computational
time.
An alternative approach that is computationally much faster is to choose a
fixed value for ∆L given by equation (5.2) for each time step ∆t and apply only
a random direction to this step. A random number q uniformly distributed
in the range [−∆L,+∆L] determines the vertical distance ∆z and thus the lateral
distance: ∆x2+∆y2 = ∆L2−q2. A second random number φ uniformly distributed
84
in the range [0, 2pi] determines the azimuthal angle and thus the diffusion steps:
∆x and ∆y according to:
∆x =
√
∆L2 − ∆z2cosφ (5.3)
∆y =
√
∆L2 − ∆z2sinφ (5.4)
Thus, while the distance of movement per time step is fixed, the direction of
movement is randomly distributed. This second approach is computationally
fast, since for each molecule and at each time step, only two uniformly dis-
tributed random numbers are required. The resulting time course is shown in
Fig. 5.1B (black curve), and is indistinguishable from the time course produced
by the simulation method using normally distributed steps (red trace in Fig.
5.1B). Therefore, all subsequent simulations were performed assuming a con-
stant ∆L per time step, since it is much faster than the method that requires a
variable ∆L per time step.
5.4.2 Determination of release sites
Molecules released from a chromaffin granule diffuse isotropically in the extra-
cellular space as indicated by fluorescence imaging [13]. When multiple elec-
trodes are utilized to detect an individual release event, the charge measured by
each electrode depends on the distance of the particular electrode from the re-
lease location. Fig. 5.2A shows the geometry of a four electrode array obtained
from an atomic force microscope image. The superimposed light-gray dots form
a two-dimensional 500 nm lattice of positions from which a large number of
molecules were assumed to be instantaneously released by vesicles at the cell
surface. Assuming instantaneous release, and for given values of the diffusion
coefficient D and the cell-detector vertical distance ZCD, the RWS for the different
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release sites provide a unique oxidation current time course for each electrode
(Fig. 5.2B), which depends on the lateral electrode-release site distance.
Figure 5.2: (A) AFM image of a four electrode array (electrodes are indicated by
different colors). Superimposed is a 500 nm lattice of simulated release locations
(gray dots) and the positions of measured exocytotic events interpolated from
the RWS (black triangles). (B) RWS results from the location in the red square of
panel (A) for N = 1, 000, 000 molecules, z = 0.1 µm and D = 600 µm2/s. Color cod-
ing as in panel (A). (C) Time courses of the integrated currents of panel (B). (D)
Fractional charges measured by the four electrodes in (A) for RWS performed
from each secretion site (gray dots in (A)). The largest fraction of molecules is
detected by the electrode located nearest to the secretory event. When secretion
occurs directly on top of one electrode, most molecules are detected by that elec-
trode, while events occurring at the ECD center are equally detected by all the
electrodes.
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The integrated current time courses (charges) shown in Fig. 5.2C correspond
to the number of molecules detected by each electrode. The fractional charges,
which are the fractions of the total detected charge that are measured by the
individual electrodes, depend primarily on the electrode-release site distances
(Fig. 5.2D). Therefore the spatial location of exocytotic events can be determined
from a comparison between the measured and simulated fractional charges,
provided that amperometric currents are recorded by at least three electrodes.
Figure 5.3: The four points (A, B,C,D) on the simulation lattice that form a
square within which release occurred X(x, y). Assuming the fractional charges
depend linearly on the spatial distances the charge Q measured at the release lo-
cation X(x, y) is calculated taking into account the contribution to the fractional
charges from both the horizontal and vertical distances.
One point on the simulation lattice will best satisfy the equation:
n∑
k=1
(
QEXP,k − QS IM,k)2 = min (5.5)
where QEXP,k and QS IM,k are the experimental and simulated fractional charges
measured by electrode k respectively, and n is the total number of electrodes
in the ECD array. A release location X(x, y) does not usually fall exactly on
a point of the 500 nm lattice but somewhere in between four lattice points
A(x1, y2), B(x2, y2),C(x1, y1),D(x2, y1) (Fig. 5.3). Therefore the simulated fractional
charges for arbitrary release locations were estimated by the following linear
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interpolation (Fig. 5.3):
QE,k(x, y2) = QA,k +
x − x1
x2 − x1 (QB,k − QA,k) (5.6)
QF,k(x, y1) = QC,k +
x − x1
x2 − x1 (QD,k − QC,k) (5.7)
QX,k(x, y) = QF,k +
y − y1
y2 − y1 (QE,k − QF,k) (5.8)
where (QA,k,QB,k,QC,k,QD,k) are the fractional charges of electrode k returned by
the RWS for the four locations (A, B,C,D) surrounding the actual release site
(Fig. 5.3). The coordinates x, y are fitted such that the interpolated fractional
charges QX,k(x, y) satisfy equation (5.5). The grid point that satisfies equation
(5.5) the best is used as the initial guess for the interpolation-based position
fit. Fig. 5.2A shows the localization of 38 experimentally measured exocytotic
events detected by at least three electrodes of the ECD array for one cell (black
triangles).
5.4.3 Time course of amperometric currents
The RWS provides not only the fractional charges but also the time course of
amperometric currents measured by the individual electrodes. To calculate nu-
merically a low-noise time course of the diffusion Dk(t) towards the individual
electrodes k = 1, .., 4, a RWS was performed for 1,000,000 molecules for the ac-
tual release location. The simulated currents (Fig. 5.2B) assuming instantaneous
release and a catecholamine diffusion coefficient D = 600 µm2/s [110] show an
amperometric spike half width of t1/2 ∼ 1 ms for the closest electrode and in-
creasing half width for the more distant electrodes as expected for the different
diffusion times. However, the measured amperometric spikes for this location
(Fig. 5.4, inset) are considerably slower with half widths of 11 to 30 ms for the
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different electrodes. This is also evident from the time course of the running
integrals of the amperometric spikes (compare Fig. 5.4 and Fig. 5.2C). This dis-
crepancy is not unexpected because previous experiments suggested that the
time course of amperometric spikes measured by a CFE at 1 µm distance from
the cell membrane was inconsistent with free diffusion following instantaneous
release [69] and several attempts have been made to deconvolve amperometric
spikes and reveal the granule secretion kinetics [89, 71, 75, 107].
5.4.4 Vesicular release time course
In ECD array experiments the amperometric current Ik(t) measured by electrode
k is the convolution of the time course of catecholamine release R(t)with the time
course of diffusion Dk(t) from the release site to electrode k:
Ik(t) =
∫ t
0
R(τ)Dk(t − τ)dτ (5.9)
Assuming the amperometric current is sampled once every ∆t, the release time
course R(t) can be approximated by a series of instantaneous release events of ni
molecules, each occurring during the time interval [ti, ti +∆t], where i = [0,m−1]
and m the total number of time points in each amperometric spike. Therefore, at
each time point the flux of molecules out of the vesicle is ji = ni∆t . Based on this
approximation, the release time course becomes:
R(t) =
m−1∑
i=0
jiδ(t − ti) (5.10)
where δ(t) is Kronecker’s delta function. Using equation (5.10) and approximat-
ing the convolution integral by a digital summation, equation (5.9) becomes:
Ik(t) =
m−1∑
i=0
2e0 jiDk(t − ti) (5.11)
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where the factor 2e0 accounts for the two electrons transferred per cate-
cholamine molecule in amperometric detection. Thus, assuming a value for the
diffusion constant D, the released amplitudes ji representing the time course
of release, can be determined as free fit parameters of a deconvolution span-
ning over all electrodes and time points. Equation (5.11) can also be used to fit
the time course of the fractional charges detected by the individual electrodes
(integrated currents normalized such that the total detected charge is 1) Qk(t)
according to the equation:
Qk(t) =
m−1∑
i=0
2e0 jiS k(t − ti) (5.12)
where S k(t) are the integrated diffusion time courses Dk(t).
Fig. 5.4 shows the results of fitting equation (5.11) and (5.12) to the currents
(inset) and normalized charges of an exocytotic event measured by the ECD
array of Fig. 5.2. The diffusion time courses Dk(t) were obtained from the RWS
using D = 600 µm2/s and numerically integrated to provide S k(t). The fitted
traces (dashed) are in good agreement with the measured data (solid) for the
two nearby electrodes (black, green traces). The fitted time course for the two
distant electrodes, however, is much faster than the measured signals (blue, red
traces) suggesting that diffusion along the cell surface is significantly slower
than assumed in the simulation.
In order to improve the fits, the diffusion coefficient D was allowed to vary as
a free fit parameter in equation (5.11). Fig. 5.5A shows RWS results for D = 600
µm2/s (red) and D = 60 µm2/s (black), with N = 100, 000 molecules for a single
5x5 µm2 electrode at 1µm distance from the cell surface. When the curves are
scaled according to the diffusion coefficient ratio (Fig. 5.5B), the shapes of the
two curves are indistinguishable. Therefore, knowledge of the diffusion time
90
Figure 5.4: Experimental (solid lines) and fitted (dashed lines) amperometric
currents (inset) and their integrals (normalized such that total charge is 1 arbi-
trary unit). The fits were performed using the RWS results for D = 600 µm2/s,
z = 0.1 µm and N = 1, 000, 000 molecules.
course Dk(t) for one value of D provides the diffusion time course Dk(t) for any
other value of D (Fig. 5.5B) by corresponding scaling, facilitating treatment of
the diffusion coefficient as a free fit parameter along with the time course of
release in equations (5.11) or (5.12).
Fig. 5.6A shows the results of fitting equation (5.11) and (5.12) to the same
data as in Fig. 5.4, but with the diffusion coefficient a free fit parameter. The
fits of Fig. 5.6A are markedly improved over those of Fig. 5.4 (for D = 600
µm2/s). The deconvolution method returned D = 110 µm2/s, which is ∼18% of
the value in free solution. For seven events from two different cells the best fits
were obtained with diffusion coefficients in the range 80 - 130 µm2/s. Thus, the
apparent diffusion coefficient near the cell surface is ∼6 times slower than that
for free diffusion. The simultaneous measurement with multiple electrodes at
different distances separates for an individual event the time course of diffusion
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Figure 5.5: (A) RWS for release occurring from the cell center directly in front of
a single 5x5 µm2 electrode using two different values for the diffusion constant:
D = 600 µm2/s (red) and D = 60 µm2/s (black). For both cases N = 1, 000, 000
molecules and z = 1µm. (B) The two RWS time courses of (A) are plotted on
different scales based on the diffusion constant ratio (left and bottom: D = 600
µm2/s, right and top: D = 60 µm2/s). Color coding is the same for both panels.
from the time course of release. The time course of release for this event of Fig.
5.6A is shown in Fig. 5.6B with a half width t1/2 ∼11 ms.
The lower diffusion coefficient may be due to reversible binding of cate-
cholamines onto the cell surface. To simulate such interactions with the cell
surface, the RWS was modified such that upon contact with the cell surface, cat-
echolamine molecules were not bounced away, but were kept bound to the cell
surface for a constant time bT and then released (transient binding). Fig. 5.7
shows the results of the RWS (not the fits to the data) using D = 110µm2/s with
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Figure 5.6: (A) Experimental (solid lines) and fitted (dashed lines) amperomet-
ric currents (inset) and their integrals (normalized such that total charge is 1
arbitrary unit). The fits were performed using the RWS results for z = 0.1 µm
and N = 1, 000, 000 molecules. The diffusion coefficient was one of the free fit
parameters. The best fit was obtained for D = 110 µm2/s. (B) Time course of
catecholamine release from a chromaffin granule revealed by the time-domain
deconvolution method for D = 600 µm2/s. The half-width of the release time
course was ∼11 ms.
bT = 0 µs (solid lines) and D = 600 µm2/s with bT = 5.0 µs (dashed lines), demon-
strating that reversible binding is consistent with the apparent slow diffusion.
It should be noted that the numerical value of bT depends on the time step used
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in the RWS and on the cell-ECD distance assumed in the RWS. When the RWS
included binding, the diffusing catecholamine molecules were bound to the cell
membrane on average 70% of their total simulation time. Thus the average ratio
of the concentration of free catecholamine molecules [F] over the concentration
of bound molecules [B] during the simulation time course is [F]/[B] = 0.43.
Figure 5.7: A comparison of the RWS results for D = 110 µm2/s with bT = 0 µs
(solid lines) and D = 600 µm2/s with bT = 5.0 µs (dashed lines). For both RWS
z = 0.1 µm and N = 1, 000, 000 molecules. Color coding same as in Fig. 5.6.
To test whether amperometric spikes recorded by CFEs are also affected by
a slow diffusion time course, RWS was performed for a single 5x5 µm2 electrode
located at 100 nm distance from the cell surface assuming an instantaneous re-
lease event. Two simulations were performed, one for D = 110 µm2/s without
binding and one for D = 600 µm2/s with bT = 5.0 µs. The t1/2 of the resulting time
courses for both conditions are shorter than 100 µs (Fig. 5.8), indicating that an
apparent diffusion ∼6-fold slower than that in free aqueous buffer would not
affect CFE amperometric spikes, which have an average t1/2 ∼ 10ms [24].
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Figure 5.8: RWS for release occurring from the cell center directly in front of a
single 5x5 µm2 electrode. D = 110 µm2/s with bT = 0 µs (red trace) and D = 600
µm2/s with bT = 5.0 µs (black trace). For both cases z = 0.1 µm and N = 1, 000, 000
molecules.
5.4.5 RWS for FSCV measurements
When a CFE is operating in FSCV mode, the molecules in contact with the elec-
trode surface are oxidized and subsequently reduced such that they are not con-
sumed. The FSCV signal that results form release of a particular vesicle thus
decays only due to the diffusion of the molecules out of the space between the
cell surface and the CFE. In the case of FSCV simulations, the CFE surface was
thus modeled as a reflecting plane, such that upon contact with it catecholamine
molecules were bounced back. In FSCV experiments the CFE is usually gently
pressed against the cell membrane such that a very small gap is created between
the cell and the electrode surfaces, therefore the cell-CFE distance was assumed
to be z = 0.1µm.
While the exact spatial location of individual exocytotic events is unknown,
it is safe to assume that exocytotic events occurring outside the membrane area
facing the CFE are unlikely to be detected since most of the catecholamine
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Figure 5.9: Averaged FSCV spike from 7 chromaffin cells. Data (dots) are pre-
sented as mean of n=104 spikes. Superimposed are the averaged RWS spikes
for D = 600 µm2/s with bT = 0 µs (solid black trace), D = 30 µm2/s with bT = 0
µs (dashed blue trace), and D = 600 µm2/s with bT = 20 µs (dashed red trace).
N = 100, 000 molecules and z = 0.1 µm for all the RWS.
molecules will not be able to diffuse into the narrow gap. Secretory events
within the 2.5 µm radius area of the cell surface facing the CFE are likely to
be uniformly distributed. To obtain representative simulations for various loca-
tions within this area, RWS was performed for five secretion sites located at the
CFE center and at a distance r of 0.5 µm, 1 µm, 1.5 µm, and 2.0 µm from the center.
These five simulated time courses were averaged with a weight equal to their
squared radii (measured from the cell center) to account for the relative cell sur-
face area with that radius. The resulting averaged curve provides the average
time course of FSCV signals in the recording. Fig. 5.9 shows the average time
course of measured FSCV spikes from 7 chromaffin cells (filled symbols) with
t1/2 ∼ 45ms. The RWS time course for a CFE in FSCV mode for the standard dif-
fusion constant D = 600µm2/s (solid black trace) gives a half-width of t1/2 ∼ 2ms,
inconsistent with the measurement. However, good agreement between the ex-
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perimental data and the simulation is obtained for RWS assuming D = 30µm2/s
with bT = 0 µs (dashed blue trace) or assuming D = 600µm2/s with bT = 20 µs
(dashed red trace), consistent with a reduced apparent diffusion coefficient due
to diffusion with binding. For z = 0.1 µm, the binding time bT = 20 µs resulted
in a [F]/[B] = 0.1 averaged for all the molecules, indicating that on average cat-
echolamine molecules were bound to the cell membrane 90% of the simulation
time.
5.5 Discussion
The novel techniques presented in this work allowed the continuous monitoring
of the spatiotemporal dynamics of chromaffin vesicle release. For this purpose,
ECD arrays were utilized in amperometric measurements of catecholamine re-
lease from chromaffin cell vesicles. The experimental data were compared with
RWS modeling catecholamine diffusion in the narrow gap formed between the
cell membrane and the ECD array coverslip.
The location of transmitter release events was identified with high spatial
precision by comparing the fractional charges measured by the individual elec-
trodes of the ECD array with the number of molecules detected by each elec-
trode in the RWS. For the identified release sites, RWS was performed to ob-
tain temporal information about the time course of catecholamine release from
single chromaffin vesicles and the time course of catecholamine diffusion from
the release site to the individual electrodes of ECD arrays. Good agreement
between the RWS and the measured amperometric data was obtained for val-
ues of the diffusion constant in the range 80-130 µm2/s, which is ∼6-fold lower
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than what would be expected for catecholamines diffusing freely in an aque-
ous buffer. The corresponding time course of catecholamine release from the
vesicles was in the range 5-8 ms, which is an overestimate due to the low pass
filtering of the amperometric currents.
The lower values of the diffusion constant determined from the deconvolu-
tions indicate hindered catecholamine motion, which may be due to cell surface
tortuosity [111] which would increase the effective length that catecholamines
have to diffuse to reach the electrodes. Alternatively, proteins and peptides ex-
truded into the extracellular space along with the catecholamines may increase
the viscosity of the solution near the release location and thus reduce the motion
of the diffusing catecholamines.
Yet another possibility is that the slow diffusion time courses are determined
by reversible binding of catecholamine molecules onto the cell membrane. Such
surface interactions were taken into account in the RWS and the resulting diffu-
sion time courses were consistent with the time courses of the measured amper-
ometric currents, indicating that reversible binding of catecholamines onto the
cell surface affects the time course of amperometric spikes measured by ECD ar-
rays. To test if reversible binding also affects the amperometric spikes measured
by CFEs, RWS was performed for release occurring directly in front of a single
electrode. The ∼6-fold lower apparent diffusion coefficient was used in the RWS
and the resulting diffusion time course had a very short half-width compared
to the typical CFE amperometric spike half-width. Therefore the time course of
CFE amperometric spikes is determined by the time course of granular release
and not the diffusion from the release site towards the CFE.
Unlike in amperometry where catecholamines are immediately oxidized at
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the electrode surface, in FSCV catecholamine molecules are reversibly oxidized
to their quinone form, which is then reduced back to the original catecholamine.
Therefore, the falling phase of a FSCV spike indicates the time course of diffu-
sion of catecholamines away from the detector surface. To investigate the time
course of FSCV spikes, RWS was also performed for a CFE operating in FSCV
mode. The simulations were compared with CFE FSCV data from chromaffin
cells. The falling phase of the RWS was much faster than the measured data
when the standard value of the diffusion constant was used. The RWS time
course was consistent with the FSCV data when a low value of the diffusion
constant was used or when reversible binding of catecholamines was taken into
account in the RWS.
The apparent diffusion constant which reproduced the FSCV data is ∼4x
lower than that which reproduced the ECD amperometric spikes. Similarly, the
binding time which reproduced the FSCV data is 4x longer than that which re-
produced the ECD amperometric data. These differences are presumably due to
catecholamine adsorption onto the CFE surface, which would only be detected
in the FSCV experiments [112, 113] and would lower the apparent diffusion
constant of catecholamines even more than reversible binding alone. The dif-
ference could also be due to smaller cell-detector distance in CFE compared to
ECD array measurements that would result in more frequent binding events at
the cell surface. In either case, reversible binding of catecholamines to bind-
ing sites on the cell surface may have a physiological role, which has yet to be
illuminated.
The RWS and the time-domain deconvolutions presented in the current
study could easily be adapted for arbitrary electrode geometries and thus find
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use in modeling transmitter release under various conditions. The dynamics of
single vesicle release can thus be investigated with unprecedented spatiotem-
poral resolution.
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CHAPTER 6
IN VIVO MEASUREMENTS OF TRANSMITTER RELEASE
6.1 Abstract
Dopamine release in the brain of freely moving research animals was monitored
with fast-scan cyclic voltammetry using carbon fiber electrodes implanted in
the striatum of the animals. Exocytotic release was elicited by a stimulating
current pulse train, using a pair of electrodes stereotaxically implanted in the
medial forebrain bundle of the animals. The animals showed complete recovery
from the stereotaxic surgery and the electrochemical measurements. To enhance
animal mobility during the experiments an electronic device with the potential
of wirelessly transmitting in vivo electrochemical data is being developed.
6.2 Introduction
Studies of exocytosis in single cells aim at understanding cellular function and
have revealed many key properties of biological cells. Despite the great wealth
of information obtained from measurements of exocytotic release in single cell,
the behavioral properties of living organisms are defined by the function of a
large number of cells, typically located within the same organ. Hence, investi-
gating transmitter release in an intact organ in a behaving animal would ulti-
mately correlate exocytosis with behavior.
The first attempts to electrochemically measure transmitter release in vivo
were made in 1978 by Wightman and coworkers [114] and soon after in 1981 by
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Gonon and coworkers [101]. However both these attempts were performed in
anesthetized animals. Therefore it was not possible to correlate neurotransmit-
ter action with animal behavior. Measurement of neurotransmitter secretion in
the brain of freely moving research animals was first achieved in 1997 by Garris
and Wightman [8]. These measurements revealed the role of the neurotransmit-
ter dopamine (DA) in various behavioral tasks, such as drug seeking [115] and
sexual behavior [116].
Stereotaxic surgery was performed for the implantation of electrodes in the
brain of rats, as well as an electronic setup for the measurement of in vivo re-
lease of DA. The surgical procedure and the setup share many similarities with
those developed in the lab of Prof. R.M. Wightman, where the author has been
trained. There are, however, some modifications (see below). At the end of
this chapter we introduce a novel electronic device, which has the capability of
transmitting electrochemical data in a wireless fashion.
6.3 Materials and methods
6.3.1 Reagents and solutions
The buffered solution used for all the in vitro voltammetric measurements con-
tained (in mM) 140 NaCl, 5 KCl, 5 CaCl2, 1 MgCl2, 10 HEPES/NaOH, 20 glucose
(pH 7.3). Dopamine hydrochloride was purchased from Sigma (Milwaukee, WI)
and used without further purification.
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6.3.2 Stereotaxic surgery
Prior to the surgery all surgical instruments were sterilized by steam steriliza-
tion. Adult Sprague-Dawley rats were housed and cared for in accordance to the
guide for care and use of laboratory animals (NIH Publication 86-23). The sur-
gical procedure was approved by the Institutional Animal Care and Use Com-
mittee of Cornell University (protocol number: 2005-0164).
On the day of the surgery, a rat was transferred to the procedure room and
immediately anesthetized with an intramuscular dosage of 87.5 mg/kg Ketamine
and 12.5 mg/kg Xylazine. Throughout the surgical procedure, the depth of anes-
thesia was monitored by palpebral reflex (response to foot pinch) every 5-10
min, and additional doses of anesthetic (half the induction volume) were admin-
istered intraperitoneally as necessary to maintain a sufficient level of anesthesia
without overdose.
The fur from the dorsal skull was shaved with an electric clipper, and the an-
imal immobilized in a Model 963 Ultra-precise small-animal stereotaxic frame
(David Kopf Instruments, Tujunga, CA). The scalp was prepped with 70% al-
cohol rinse and iodine scrub. Following induction of local anesthesia at the
periosteum with 2 mg/kg bupivicain, an incision was made to the level of the
skull using scissors and the scalp was retracted with tweezers. The incision area
was cleaned with hydrogen peroxide.
Lambda and bregma were adjusted, such that they were completely flat, as
measured by the stereotaxic instrument. Target coordinates were determined
based upon distance from Bregma as measured using the stereotaxic instrument
and an operating microscope (Omano, Wirtz, VA). Coordinates were derived
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from the Paxinos and Watson rat brain atlas [117] and are presented in units of
millimeters (mm).
Three burr hole sites were marked, one for the working electrode at anterior-
posterior (AP): +1.20 and medio-lateral (ML): +2.00, and two for the stimulating
electrodes at AP: -4.56, ML: +1.40, and AP: -4.56, ML: +2.40. Five additional burr
hole sites were marked, four for the surgical screws to mount the cement on the
animal’s head, and one for the reference electrode (on the side contralateral to
the stimulating and working electrodes).
Burr holes were made through the skull with a high speed drill (Model 395
MultiPro, Dremel, Racine, WI), with care taken not to violate the dura. At the
sites of the stimulating electrodes, dural incisions were made by nicking the
dura with the sharp edge of a 30G needle. Any dural bleeding was controlled
by filling the burr hole with hypertonic saline (7.5% NaCl in distilled water)
and observing for a brief period. Typically dural bleedings stopped after a short
period, with insignificant blood loss.
Four stainless steel surgical mounting screws (part number: 0-80 X 1/8, Plas-
tics One, Roanoke, VA) were half way tightened in the burr holes using a screw-
driver. A guide cannula (part number: MD-2251, Bioanalytical Systems, West
Lafayette, IN) was mounted on the stereotaxic frame holder (rod part number:
MD-1521, clamp part number: MD-1520, Bioanalytical Systems, West Lafayette,
IN) and inserted in the burr hole located at AP: +1.20, ML: +2.00. A bare sil-
ver wire of length ∼1.5 cm and thickness 200 µm (part number: 782000, A-M
Systems, Sequim, WA) was chlorinated (Ag|AgCl), soldered to a gold pin (part
number: 82K7797, Newark, Chicago, IL) and inserted at the site of the reference
electrode. The four surgical screws, the cannula and the reference electrode
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were mounted on the animal’s head using dental cement (part number: 675570,
DentSply Caulk, Milford, DE). After the cement had solidified (typically within
5-10 min) the guide cannula was detached from the stereotaxic frame holder, and
the holder was retracted.
The dual stimulating electrodes (250 µm diameter stainless steel wires, in-
sulated with polyimide except their tips, part number: MS303/1, Plastics One)
were mounted on the stereotaxic frame and inserted 8 mm in the brain. The
depth was measured using the stereotaxic frame and the operating microscope.
The stimulating electrodes were connected to an optically isolated current stim-
ulator (Model 2200, A-M Systems) and a bipolar current pulse train (24 pulses,
4 ms duration per pulse, 100 µA amplitude, 60 Hz frequency) was applied to
the electrodes. The stimulating electrodes were further lowered in the brain at
0.2 mm increments, until the animal’s response to the stimulating current pulse
train was minimized. Typically, this occurred at 8.5-9.0 mm dorso-ventral (DV)
depth. Dental cement was added onto the electrodes and when the cement had
solidified, the stereotaxic frame’s arm was retracted. Fig. 6.1 shows a pair of
stimulating electrodes in the AP section of the brain where the electrodes were
implanted.
The animal was removed from the stereotaxic frame, 1mL lactated ringer
solution and 2 mg/kg Yohimbine were administered intraperitoneally, and the
animal was transferred to its cage and allowed to recover. Body temperature
was maintained at appropriate levels using a lamp. After waking up, the animal
was returned to the housing facility, singly housed to avoid destruction of the
surgical site by other animals, and allowed to recover for at least 3 days. Food
and water were available ad libitum. For days 1 and 2 following surgery, the
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Figure 6.1: A pair of stimulating electrodes in the medial forebrain bundle.
Gray: polyimide insulation, black: exposed stainless steel electrodes. Only the
right cerebral hemisphere is shown. Schematic not drawn to scale. Figure mod-
ified from [117].
animal was administered 2 mg/kg Ketoprofen. If the animal had not regained its
pre-surgery weight, 1 mL lactated Ringer solution was also administered daily.
Both Ketoprofen and the Ringer solution were administered intraperitoneally.
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6.3.3 Carbon fiber electrode fabrication
Carbon fiber electrodes (CFEs) were fabricated by inserting a single carbon fiber
(5.0 µm diameter) in a borosilicate glass capillary (0.6 mm outer diameter, part
number: 624503, A-M Systems). The capillary was then pulled using a pipette
puller (Model P-97, Sutter instrument) producing two electrodes, which were
separated with scissors. CFE tips were cut using a blade (No 10, Feather Safety
55 Razor Co, Japan) such that the protruding cylindrical electrodes were ∼75-
100 µm long. Immediately prior to experiments, a silver wire coated with silver
paint was inserted in the glass capillary to connect the CFE to the amplifier.
6.3.4 Manipulator for inserting the CFE in the brain
During recordings a glass-encased CFE was lowered through the guide cannula
into the animal’s brain. For this purpose, a custom built (machine shop, School
of Applied and Engineering Physics, Cornell University, Ithaca, NY) manipula-
tor (Fig. 6.2) was utilized.
To avoid breaking its tip, the top part of the CFE was inserted in the ma-
nipulator from the part where the male-end connector to the guide cannula is
located (see bottom of Fig. 6.2). The manipulator was then mounted onto the
guide cannula implanted in the animal’s head. The precision screw of the ma-
nipulator allows the precise control of the DV position of the CFE. A black foam
(shown at the top of Fig. 6.2) prevents the CFE from sliding in the manipulator
chamber. The lock secures the precision screw such that the DV position of the
CFE is fixed. A schematic of a CFE in the striatum is shown in Fig. 6.3. The
original design and fabrication of this manipulator was developed at the lab
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Figure 6.2: Manipulator for inserting the CFE in the animal’s brain. The ma-
nipulator can be mounted and locked on the guide cannula. A precision screw
(82 threads per inch, resulting in a vertical movement of ∼310 µm per full turn)
adjusts the CFE dorso-ventral position. Photo: courtesy of O.D. Escanilla.
of Prof. R.M. Wightman in the Department of Chemistry at the University of
North Carolina at Chapel Hill.
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Figure 6.3: A CFE in the caudete putamen. Black: glass pipette, gray: pro-
truding carbon fiber. Only the right cerebral hemisphere is shown. The guide
cannula through which the CFE is lowered in the brain is not shown. Schematic
not drawn to scale. Figure modified from [117].
6.3.5 Data detection and amplification apparatus
The CFE was connected via a gold contact pin to the negative input terminal
of a low noise amplifier (OPA111AM, Texas Instruments, Dallas, TX), soldered
onto a custom built circuit board. Fig. 6.4 shows the circuit design. The low
noise amplifier was configured with negative feedback (R f in parallel with C f )
creating a low-pass filter of ∼6.4 kHz cutoff frequency. The CFE voltammetric
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current was converted to a voltage through the feedback resistor. To subtract
the applied potential a differential amplifier (OP27G, Texas Instruments) was
used with 10 kΩ input and feedback resistors. Four capacitors were used to
reduce the power supply voltage noise (lower left of Fig. 6.4).
Figure 6.4: Electronic circuit for in vivo measurements. Values of passive com-
ponents: R f = 5MΩ, C f = 5pF, R1 = R2 = 10kΩ.
6.3.6 Data acquisition hardware and software
The electronic circuit of Fig. 6.4 was interfaced with a personal computer using
a commercially available data acquisition setup (Heien Instruments, Normal,
IN) which utilized two PCI boards (PCI-6711 and PCI-6052 both by National
Instruments). The software Tar Heel CV (Heien Instruments) was utilized to
apply the potential waveform to the CFE, digitize the CFE current, apply the
stimulating pulse train to the bipolar stimulating electrodes, and generate all
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the necessary control signals.
6.3.7 Fast-scan cyclic voltammetry
Fast-scan cyclic voltammetry (FSCV) was performed using a voltage waveform
applied to the working CFE versus the reference Ag|AgCl wire that consisted
of a 9.3 ms triangular segment, during which the electrode voltage was scanned
from -400 mV to +1,300 mV and back to -400 mV at a rate of ±400 V/s respec-
tively. The peak potential of this waveform was extended to +1,300 mV because
overoxidation of CFEs enhances DA detection [97]. The triangular segment was
followed by a resting period during which the electrode potential was constant
at -400 mV (Fig. 6.5). The total duration of the applied potential was 100 ms.
Voltammetric currents were digitized at ∼117 kHz sampling rate. Experiments
were performed at room temperature.
Figure 6.5: Potential waveform applied to the CFE during in vivo measurements.
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6.4 Results
6.4.1 In vivo recordings with wired setup
On the day of the experiments, the animal was brought from the animal hous-
ing facility and placed in a plexiglass box located inside a Faraday cage to per-
form low-noise in vivo electrochemical measurements. A CFE was placed in the
manipulator (Fig. 6.2) and carefully inserted in the animal’s striatum. The im-
planted bipolar stimulating electrodes were connected to a current stimulator.
The voltage waveform shown in Fig. 6.5 was repetitively applied to the CFE.
Fig. 6.6 shows the CFE current sampled at the +522 mV point of the anodic
ramp (positive slope). At t=5 s, dopaminergic neurons were stimulated by a
bipolar current pulse train (24 pulses of amplitude 100 µA, duration 4 ms and
frequency 60 Hz). The transient increase in the oxidation current is correlated
with the onset of the stimulating pulse train, the duration of which is indicated
by the two gray squares in Fig. 6.6.
The current responses during the first 50 voltammetric cycles (0 - 4.9 s) was
averaged to obtain the background current. The following 10 cycles (5-5.9 s)
were averaged providing an average background+redox signal. Their differ-
ence (redox current) plotted versus the applied potential is shown in Fig. 6.7
and reveals the signature voltammogram of DA molecules. Fig. 6.8 shows the
background-subtracted voltammogram for the sweep of the peak oxidation cur-
rent, which occurred at t=5.5 s (the background current was the same as in Fig.
6.7). The voltammogram of Fig. 6.8 indicates that the oxidation current was due
to increased DA levels in the vicinity of the CFE.
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Figure 6.6: In vivo recording of CFE current sampled at the +522 mV applied
potential and plotted versus time. The two gray squares indicate the duration
of the stimulating pulses (24 bipolar pulses, at 60 Hz frequency and with 100 µA
amplitude).
Figure 6.7: The current of the first 50 (0-4.9 s) voltammetric cycles of Fig. 6.6 was
averaged to determine the background signal. The following 10 cycles (5-5.9 s)
were averaged to obtain the average background+redox signal. Their difference
plotted versus the applied potential is the background-subtracted voltammo-
gram.
Figs. 6.9 and 6.10 are similar to Figs. 6.6 and 6.7 respectively, with the differ-
ence that the amplitude of the stimulating pulses was increased from 100 to 300
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Figure 6.8: Background-subtracted voltammogram for the peak current of Fig.
6.6 which occurred at t=5.5 s. For the subtraction, the same background current
as in Fig. 6.7 was used.
µA. The same CFE and the same animal were used for both measurements. The
amplitude of the measured oxidation current is larger for the 300 µA amplitude
stimulating pulses, compared to the 100 µA amplitude pulses. A comparison of
the oxidation currents in Figs. 6.6 and 6.9 indicates that the oxidation current
does not depend linearly on the stimulating pulse amplitude.
6.4.2 Modified apparatus for data detection and amplification
To measure FSCV currents in vivo, the data detection system is required to have a
high dynamic range due to the very large capacitive background currents (black
trace of Fig. 6.11A) generated at the interface between the CFE and the elec-
trolyte (brain extracellular matrix), when fast voltage ramps are applied to the
CFE. The redox current generates only a small change on top of the background
current (dashed red trace of Fig. 6.11A). In wired setups, the amplifier supply
voltage is typically ±10 V , and the gain is adjusted such that the redox current is
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Figure 6.9: In vivo recording of CFE current sampled at the +662 mV applied
potential and plotted versus time. The two gray squares indicate the duration
of the stimulating pulses (24 bipolar pulses, at 60 Hz frequency and with 300 µA
amplitude).
Figure 6.10: The current of the first 50 (0-4.9 s) voltammetric cycles of Fig. 6.9
was averaged to construct the background current. The current for 15 voltam-
metric cylces starting at 5.2 s was averaged to construct the DA signal. The
difference (redox minus background) of the two plotted versus the applied po-
tential (background-subtracted voltammogram).
well above noise levels and background-subtracted voltammograms of DA are
clearly detected (Fig. 6.11B). A wireless device, however, must operate with a
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battery, which typically generates a voltage of ∼3 V . In this case the dynamic
range requirement becomes a significant limitation.
Figure 6.11: (A) FSCV current for a CFE in the buffer solution containing 0 µM
(black trace) and 1 µM DA (dashed red trace) respectively. The CFE was con-
nected to an EPC-8 amplifier (HEKA-Elektronik, Germany). (B) Background-
subtracted voltammogram.
To lower the dynamic range requirement, the electronic device was modi-
fied, such that in addition to the low-noise amplifier (LNA) that detected the
CFE current, a second identical LNA was connected to the series combination
of an electrical resistor RC and a capacitorCC (Fig. 6.12). This series combination
models the Debye double layer at the CFE-electrolyte interface. The capacitance
value was chosen as CC = 1 nF, because this value is typical for in vivo record-
ings during which 100 µm long CFEs (2.5 µm radius tip) are typically used. The
double layer capacitance of the electrode is approximately: C = 0 Ad = 1.1 nF,
where A is the electrode area, d the Debye length (∼1 nm for physiological saline),
0 the permittivity of vacuum (8.85 pF/m), and  = 80 the dielectric constant of
water.
Fig. 6.13A shows the FSCV current of the CFE utilized in the measurements
of Fig. 6.11. The CFE was placed in the buffer solution and connected to the
electronic circuit of Fig. 6.12. When the voltage ramps were applied, both the
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Figure 6.12: Design of the electronic circuit for wireless FSCV. The circuit in-
cludes a capacitance compensation to lower the dynamic range requirement.
Values of passive components: R f = 1MΩ,C f = 25pF,R1 = 40kΩ,R2 = 80kΩ,R3 =
2.7kΩ,RC = 100kΩ,CC = 1nF. The low-noise amplifiers are two LMV751 opamps
(National Semiconductor, Santa Clara, CA), while the differential amplifiers are
both in the same INA2132 integrated circuit (Texas Instruments, Dallas, TX).
These components were as in [118].
capacitor at the CFE-electrolyte interface and the compensation capacitorCC are
simultaneously charged and discharged. The background current (black trace
of Fig. 6.13A) is reduced ∼5-fold by the capacitance compensation, and as a re-
sult the redox current (red trace of Fig. 6.13A) is clearly apparent (compare to
Fig. 6.11A). The reduction of the background current allows three times higher
amplification of the measured current at the subsequent stage (differential am-
plifier at the right of Fig. 6.12). The background-subtracted voltammogram
averaged over a 10 s period is shown in Fig. 6.13B.
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Figure 6.13: (A) FSCV current for a CFE in the buffer containing 0 µM (black
trace) and 1 µM DA (red trace) respectively. The CFE was connected to the elec-
tronic circuit of Fig. 6.12. (B) Background-subtracted voltammogram averaged
over a 10 s segment. The same CFE as in Fig. 6.11 was used.
The circuit of Fig. 6.12 also includes a differential amplifier (lower left sec-
tion) which applies a constant potential to the Ag|AgCl reference electrode. This
reference potential is necessary in order to apply a bipolar voltage ramp and
measure both positive and negative (oxidation and reduction) currents. The
noise levels of the currents measured with the circuit of Fig. 6.12 are relatively
high as can be seen in the voltammetric current recordings of Fig. 6.13A. The
reasons for the higher noise levels are still unclear.
6.4.3 Wireless transmission of FSCV data
In order to correlate neurotransmitter action with behavior, it is necessary to
allow animals to freely move during electrochemical recordings. When the an-
imal’s head is connected with wires to the detection apparatus, the animal is
restrained and not completely free to move. Therefore it is desirable to wire-
lessly transmit the recorded electrochemical data from the animal’s brain to a
recording device.
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A setup for bidirectional wireless communication typically consists of a base
station (BS) and a remote unit (RU). The BS is the immobile unit, while the RU
is mounted on the mobile object. To allow maximal flexibility for the FSCV
experiments, the BS and the RU communicate in a bidirectional wireless fashion.
The potential waveform applied to the CFE is transmitted from the BS to the RU,
while the measured FSCV current is transmitted from the RU to the BS.
Bluetooth technology has been used for wireless FSCV measurements [118].
For our experiments, we utilized a commercially available integrated chip
(F2M03MLA, Free2Move, Halmstad, Sweden), which requires a supply poten-
tial of 3.1 − 3.6 V , and has 75 mA maximum current consumption during RF
transmission. The F2M03MLA module contains 16-bit resolution analog-to-
digital and digital-to-analog converters, an audio codec, and a Bluetooth wire-
less transceiver.
The analog input data are digitized and converted into A2DP (Advanced
Audio Distribution Profile) format in the F2M03MLA module. The firmware
currently available for the F2M03MLA module allows operation in A2DP for-
mat only in sink mode (receive) and not in source mode (transmit). Thus data
in A2DP format are received by the RU, but not yet transmitted from the RU to
the BS.
Fig. 6.14A shows the FSCV current of a CFE in a buffer containing 0 µM
(black trace) and 1 µM DA (red trace) respectively. Fig. 6.14B shows the corre-
sponding background-subtracted voltammogram.
The measured data was stored in a personal computer (PC), converted to
A2DP format, and wirelessly transmitted from the PC to the RU using a Blue-
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Figure 6.14: (A) (A) FSCV current measured in a buffer containing 0 µM (black
trace) and 1 µM DA (red trace) respectively. (B) Corresponding background-
subtracted voltammogram. Recordings were made with an EPC-8 amplifier
(Heka Elektronik, Germany) connected to an ITC-18 data converter (Instrutech
Corp, Bellmore, NY).
tooth Universal Serial Bus adapter (GBU221, IOGEAR Inc., Irvine, CA). The data
received at the RU was again digitized with the ITC-18 data acquisition board
and is shown in Fig. 6.15A and B. This serves as a proof of principle that the
A2DP data transmission format is suitable for wireless in vivo FSCV, such that
future implementation of reverse direction A2DP in the firmware should make
the device a complete bidirectional telemetric system.
Figure 6.15: (A) The data of Fig. 6.14A after wireless transmission using the
A2DP Bluetooth protocol. (B) Background-subtracted voltammogram of the re-
ceived data averaged over a 10 s period.
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6.5 Discussion
In vivo monitoring of neurotransmitter levels is a powerful tool which can illu-
minate the role of neurotransmitters in animal behavior. Detection of DA in the
brain of freely moving rats was presented above. DA release was elicited by a
stimulating current pulse train. Comparing Figs. 6.6 and 6.9, one can see that
the oxidation current does not depend linearly on the stimulating pulse ampli-
tude, presumably because neuronal stimulation has a non-linear dependence
on the amplitude of the stimulating pulses.
The in vivo data presented above were obtained using a working CFE con-
nected with wires to the data acquisition setup. To truly correlate neurotrans-
mitter action with animal behavior, a wireless setup is needed, in order to pro-
vide complete freedom of motion to the research animals. The principal design
of such a wireless device was presented. The device includes a simple capaci-
tance compensation circuit, which subtracts directly on the chip part of the back-
ground FSCV current, increasing the signal to background ratio. This allows
higher amplification of the data before their wireless transmission, thus improv-
ing the dynamic range. Although the wireless system tested in the present work
is not yet bidirectional, future firmware improvements could make the device
fully bidirectional, making it suitable for in vivo FSCV measurements.
121
CHAPTER 7
CONCLUSIONS AND OUTLOOK
Electrochemical measurements of oxidizable neurotransmitters such as
dopamine, norepinephrine, epinephrine and serotonin have revealed a wealth
of information from single vesicle release in cultured cells to neurosecretion
measurements in the brain of living animals. This thesis presents technical de-
velopment and experimental results on both levels.
In the present work, cell-attached capacitance measurements and amperom-
etry were utilized in single chromaffin cells where either actin polymerization
or nonmuscle myosin II function was inhibited. The results indicated that the
rate of catecholamine secretion from single chromaffin vesicles is enhanced by
the functions of F-actin and nonmuscle myosin II. These experiments also pro-
vided the first direct evidence that F-actin facilitates the expansion of the early
fusion pore.
These novel findings indicate that exocytosis in neuroendocrine cells does
not merely depend on the SNARE complex formation; there is rather a multi-
tude of intracellular proteins that contribute to vesicle fusion and secretion. Un-
covering the dynamic interplay between the various intracellular molecules that
contribute to vesicle formation, fusion and release will shed more light into the
details of the amount of neurotransmitters (quantal size) stored in single vesicles
and their secretion time course. Both quantal size and transmitter release time
course have huge biomedical significance. Several neurological diseases, such
as Parkinson’s disease and Alzheimer’s disease, are correlated with the in vivo
levels of neurotransmitters, regulated by vesicular release [119]. Understand-
ing the fundamental mechanisms of vesicle formation and secretion will thus
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facilitate the development of treatments for these devastating diseases. It could
be possible to design drugs that would increase the amount of neurotransmit-
ters stored within vesicles or accelerate the rate at which vesicles release their
contents. In Parkinson’s disease such treatments increase striatal dopamine lev-
els thereby compensating at least in part for the reduction of dopamine due to
neuronal degeneration.
The improved platinum electrodes (PtEs) developed in the present work
resulted in mechanically robust and chemically stable devices, enriching the
toolkit available to biophysicists, electrochemists and neuroscientists. Due to
all their advantages demonstrated in Chapter 4, we anticipate the electrochem-
ical detector arrays to be utilized in various experiments providing a better un-
derstanding of the molecular machinery underlying exocytosis in different cell
types, including neurons. It could also be possible to use the SiO2-insulated
PtEs as a medical diagnostic tool, by chronically implanting them to moni-
tor in vivo neurotransmitter levels. In the current work we developed a tech-
nique to pattern a chemical stimulus at a specific spatial location with microm-
eter precision, and electrochemically monitor catecholamine secretion as cellu-
lar response to the patterned stimulus. This technique could address issues
such as cell membrane compartmentalization and spatiotemporal dynamics of
stimulus-secretion coupling. For instance, in an experiment utilizing a multi-
electrode array, a chemical stimulus may be patterned near one electrochemical
detector to stimulate a region of the cell near that electrode. Simultaneous am-
perometric recordings by the different electrodes in the array will indicate how
secretion is localized relative to spatial localization of the patterned stimulus,
indicating if local stimulation induces local release or if the stimulus spreads
through the cell inducing release from different regions of the cell membrane.
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Random walk simulations are well suited for modeling molecular motion in
arbitrary geometries [43]. The RWS as well as the time-domain deconvolution
developed in the present work revealed that in addition to secretion, the amper-
ometric spikes measured with an ECD array are also affected by the diffusion
of catecholamines towards the individual detectors. The data were fitted well
using values of the diffusion constant smaller than that of catecholamines dif-
fusing in an aqueous solution. The RWS indicated that the slow diffusion rate
may by due to reversible binding of catecholamines onto the cell surface. The
RWS is not restricted by any particular geometric constraint, it can thus be used
for modeling catecholamine motion in a glass pipette in patch-amperometry ex-
periments. RWS can also model neurotransmitter secretion in vivo, for example
in a three dimensional reconstruction of the striatum.
Electrochemistry in the brain of research animals is a powerful tool which
has allowed correlating the role of dopamine in behavior [115, 116]. The setups
currently utilize a carbon fiber electrode connected to the detection apparatus
with wires, which hinder animal motion. A wireless setup would thus be an
invaluable tool for neuroscientists to investigate the role of neurotransmitters
in behavior. The technique of capacitance compensation presented in Chapter
6 of this thesis should serve as a first step towards the development of such a
device. Although more sophisticated methods of removing the capacitive back-
ground current of FSCV measurements have been developed [120], they would
require complicated hardware and would be difficult to implement in wireless
measurements. The method presented in Chapter 6 is a very simple one, which
has minimum space and power consumption requirements. Coupled with a
reasonably good bidirectional telemetry system, this method should enable the
wireless monitoring of DA in the brain of freely behaving animals. In addi-
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tion to serving as a fundamental research tool for neuroscientists, such a device
could also serve as a therapeutic instrument. As an example, this device could
be coupled with a deep brain stimulation system, which is a technique used for
the real time treatment of Parkinson’s disease patients. When the wireless DA
sensor would detect critically low DA levels in the striatum, it would initiate the
deep brain stimulation system, such that striatal DA levels would be increased
before the patient starts experiencing the devastating symptoms of Parkinson’s
disease.
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